<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">NPJ Digit Med</journal-id><journal-id journal-id-type="iso-abbrev">NPJ Digit Med</journal-id><journal-id journal-id-type="pmc-domain-id">3605</journal-id><journal-id journal-id-type="pmc-domain">npjdigitmed</journal-id><journal-title-group><journal-title>NPJ Digital Medicine</journal-title></journal-title-group><issn pub-type="epub">2398-6352</issn><publisher><publisher-name>Nature Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11739375</article-id><article-id pub-id-type="pmcid-ver">PMC11739375.1</article-id><article-id pub-id-type="pmcaid">11739375</article-id><article-id pub-id-type="pmcaiid">11739375</article-id><article-id pub-id-type="pmid">39820131</article-id><article-id pub-id-type="doi">10.1038/s41746-024-01312-4</article-id><article-id pub-id-type="publisher-id">1312</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>A systematic review of machine learning applications in predicting opioid associated adverse events</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-0611-4389</contrib-id><name name-style="western"><surname>Ram&#237;rez Medina</surname><given-names initials="CR">Carlos R.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Benitez-Aurioles</surname><given-names initials="J">Jose</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-6687-3507</contrib-id><name name-style="western"><surname>Jenkins</surname><given-names initials="DA">David A.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-1487-277X</contrib-id><name name-style="western"><surname>Jani</surname><given-names initials="M">Meghna</given-names></name><address><email>meghna.jani@manchester.ac.uk</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/027m9bs27</institution-id><institution-id institution-id-type="GRID">grid.5379.8</institution-id><institution-id institution-id-type="ISNI">0000000121662407</institution-id><institution>Centre for Epidemiology Versus Arthritis, Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, </institution><institution>The University of Manchester, </institution></institution-wrap>Manchester, United Kingdom </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/027m9bs27</institution-id><institution-id institution-id-type="GRID">grid.5379.8</institution-id><institution-id institution-id-type="ISNI">0000 0001 2166 2407</institution-id><institution>Division of Informatics, Imaging and Data Science, </institution><institution>The University of Manchester, </institution></institution-wrap>Manchester, United Kingdom </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04rrkhs81</institution-id><institution-id institution-id-type="GRID">grid.462482.e</institution-id><institution-id institution-id-type="ISNI">0000 0004 0417 0074</institution-id><institution>NIHR Manchester Biomedical Research Unit, Manchester University NHS Foundation Trust, </institution><institution>Manchester Academic Health Science Centre, </institution></institution-wrap>Manchester, United Kingdom </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/027rkpb34</institution-id><institution-id institution-id-type="GRID">grid.415721.4</institution-id><institution-id institution-id-type="ISNI">0000 0000 8535 2371</institution-id><institution>Salford Royal Hospital, </institution><institution>Northern Care Alliance, </institution></institution-wrap>Salford, United Kingdom </aff></contrib-group><pub-date pub-type="epub"><day>16</day><month>1</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>8</volume><issue-id pub-id-type="pmc-issue-id">478273</issue-id><elocation-id>30</elocation-id><history><date date-type="received"><day>5</day><month>3</month><year>2024</year></date><date date-type="accepted"><day>24</day><month>10</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>16</day><month>01</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>17</day><month>01</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-01-28 23:25:24.730"><day>28</day><month>01</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#8217;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#8217;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="41746_2024_Article_1312.pdf"/><abstract id="Abs1"><p id="Par1">Machine learning has increasingly been applied to predict opioid-related harms due to its ability to handle complex interactions and generating actionable predictions. This review evaluated the types and quality of ML methods in opioid safety research, identifying 44 studies using supervised ML through searches of Ovid MEDLINE, PubMed and SCOPUS databases. Commonly predicted outcomes included postoperative opioid use (<italic toggle="yes">n</italic>&#8201;=&#8201;15, 34%) opioid overdose (<italic toggle="yes">n</italic>&#8201;=&#8201;8, 18%), opioid use disorder (<italic toggle="yes">n</italic>&#8201;=&#8201;8, 18%) and persistent opioid use (<italic toggle="yes">n</italic>&#8201;=&#8201;5, 11%) with varying definitions. Most studies (96%) originated from North America, with only 7% reporting external validation. Model performance was moderate to strong, but calibration was often missing (41%). Transparent reporting of model development was often incomplete, with key aspects such as calibration, imbalance correction, and handling of missing data absent. Infrequent external validation limited the generalizability of current models. Addressing these aspects is critical for transparency, interpretability, and future implementation of the results.</p></abstract><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Epidemiology</kwd><kwd>Outcomes research</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100000272</institution-id><institution>DH | National Institute for Health Research (NIHR)</institution></institution-wrap></funding-source><award-id>NIHR301413</award-id><principal-award-recipient><name name-style="western"><surname>Jani</surname><given-names>Meghna</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>National Institute for Health and Care Research [NIHR]. MJ is supported by an NIHR Advanced Fellowship [NIHR301413].</institution></funding-source></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; Springer Nature Limited 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par2">Opioids, a class of medications used to treat acute and chronic pain, are associated with persistent use, adverse events, unintentional overdoses, and deaths<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. In 2020, nearly 70,000 opioid-related overdose deaths were reported in the United States<sup><xref ref-type="bibr" rid="CR2">2</xref>,<xref ref-type="bibr" rid="CR3">3</xref></sup>. Although opioid mortality rates in other countries have not reached these levels, the adverse consequences of prescription opioid use are increasing in countries such as Canada, Australia, and the United Kingdom parallel to increasing prescription use<sup><xref ref-type="bibr" rid="CR4">4</xref>&#8211;<xref ref-type="bibr" rid="CR7">7</xref></sup> In response to the global impact of harmful opioid use on public health, international efforts have intensified to combat the opioid crisis through the development of effective prevention and treatment strategies<sup><xref ref-type="bibr" rid="CR8">8</xref></sup>.</p><p id="Par3">There has been growing interest in using machine learning (ML) to improve diagnosis, prognosis, and clinical decision-making, a trend largely driven by the widespread availability of large-volume data, such as electronic health records (EHRs) and advances in technology<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>. ML techniques have shown promise in handling large, nonlinear, and high-dimensional datasets and modelling complex clinical scenarios, offering flexibility over traditional statistical models<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>. However, despite their potential, ML applications in healthcare have not consistently led to improved patient outcomes<sup><xref ref-type="bibr" rid="CR10">10</xref></sup> and often fail to achieve notable clinical impact.<sup><xref ref-type="bibr" rid="CR11">11</xref>,<xref ref-type="bibr" rid="CR12">12</xref></sup> The increasing complexity of ML models such as gradient-boosted machines, random forests, and neural networks can reduce their transparency and interpretability, limiting their application within clinical practice.<sup><xref ref-type="bibr" rid="CR13">13</xref>&#8211;<xref ref-type="bibr" rid="CR15">15</xref></sup> Model development is often driven more by data availability than by clinical relevance<sup><xref ref-type="bibr" rid="CR16">16</xref></sup>, with performance gains not always justifying the trade-off between accuracy and interpretability<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>. Although several ML models have been developed recently to predict opioid-related harms, their clinical utility remains uncertain. We conducted a systematic literature review to identify and summarise available ML prediction models pertaining to opioid-related harm outcomes and assess strengths, limitations, and risk of bias in these studies, providing an overview of the current state-of-the-art ML methods in opioid-drug safety research.</p></sec><sec id="Sec2" sec-type="results"><title>Results</title><sec id="Sec3"><title>Study selection</title><p id="Par4">The search yielded 1315 studies (Fig. <xref rid="Fig1" ref-type="fig">1</xref>) 347 studies were identified as duplicates, and 894 were excluded after title/abstract screening. Seventy-four full-text articles were retrieved for full review. Among excluded studies, 11 did not use ML methods, six described studies that did not develop predictive models as the main objective, and three relied on data sources other than those in the scope of the review. The flow diagram outlining the study selection process and displaying detailed results of our literature search in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) can be found in Fig. <xref rid="Fig1" ref-type="fig">1</xref>.<fig id="Fig1" position="float" orientation="portrait"><label>Fig. 1</label><caption><title>PRISMA flowchart.</title><p>This flowchart illustrates the inclusion and exclusion of studies at each stage of the systematic review process.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e288" position="float" orientation="portrait" xlink:href="41746_2024_1312_Fig1_HTML.jpg"/></fig></p></sec><sec id="Sec4"><title>Overview of included studies</title><p id="Par5">All eligible studies were published between 2017 and 2023, with most of them performed in 2021 (<italic toggle="yes">n</italic>&#8201;=&#8201;11, 25%, Supplementary Table <xref rid="MOESM1" ref-type="media">1</xref>). Studies were mainly conducted with data from the United States (<italic toggle="yes">n</italic>&#8201;=&#8201;39,88.6%), with some studies originating in Canada<sup><xref ref-type="bibr" rid="CR18">18</xref>&#8211;<xref ref-type="bibr" rid="CR20">20</xref></sup> (<italic toggle="yes">n</italic>&#8201;=&#8201;3, 6.8%), Iran (<italic toggle="yes">n</italic>&#8201;=&#8201;1,2.3%)<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>, and Switzerland (<italic toggle="yes">n</italic>&#8201;=&#8201;1,2.3%)<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>. The majority used EHRs as the main data source (<italic toggle="yes">n</italic>&#8201;=&#8201;31, 70%) as opposed to administrative data, with a retrospective cohort study design to perform their analysis. External validation, vital for evaluating the generalisability of the models, was rare and identified for only five studies<sup><xref ref-type="bibr" rid="CR23">23</xref>&#8211;<xref ref-type="bibr" rid="CR27">27</xref></sup>. For two studies this external validation was conducted within the same study of the model creation using a separate dataset<sup><xref ref-type="bibr" rid="CR26">26</xref>,<xref ref-type="bibr" rid="CR27">27</xref></sup>, and for three models we identified independent studies that aimed to validate the models&#8217; performance in a different setting<sup><xref ref-type="bibr" rid="CR23">23</xref>,<xref ref-type="bibr" rid="CR25">25</xref></sup>. The performance of the machine learning models assessed in the reviewed studies varied widely, with area under the receiver operating characteristic curve (AUC) values ranging from 0.68<sup><xref ref-type="bibr" rid="CR28">28</xref></sup> to 0.96<sup><xref ref-type="bibr" rid="CR29">29</xref></sup> (Table <xref rid="Tab1" ref-type="table">1</xref>). We caution against direct comparison due to differences in training and testing settings across studies. Variations include differences in datasets used, outcomes measured, data partition sizes, and the specific models employed.<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Description of included studies that focussed on machine learning in opioids-associated adverse outcomes</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">Study</th><th colspan="1" rowspan="1">Category</th><th colspan="1" rowspan="1">Data</th><th colspan="1" rowspan="1">Country</th><th colspan="1" rowspan="1">ML Algorithm</th><th colspan="1" rowspan="1">Best Performing Model</th><th colspan="1" rowspan="1">Results of best performing model</th><th colspan="1" rowspan="1">Model Calibration</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">Behnoush et al. <sup><xref ref-type="bibr" rid="CR21">21</xref></sup></td><td colspan="1" rowspan="1">Seizure due to acute tramadol poisoning</td><td colspan="1" rowspan="1">EHRs</td><td colspan="1" rowspan="1">Iran</td><td colspan="1" rowspan="1">SVM, NB, ANN, KNN</td><td colspan="1" rowspan="1">Logistic Regression</td><td colspan="1" rowspan="1">NB (0.71)</td><td colspan="1" rowspan="1">Not performed</td></tr><tr><td colspan="1" rowspan="1">Anderson et al. <sup><xref ref-type="bibr" rid="CR58">58</xref></sup></td><td colspan="1" rowspan="1">Postsurgical Opioid Use</td><td colspan="1" rowspan="1">EHRs</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">BBN, RF, GBM, LR</td><td colspan="1" rowspan="1">GBM</td><td colspan="1" rowspan="1">GBM (AUC. 77, Brier score.10)</td><td colspan="1" rowspan="1">Calibration plots &amp; Brier Score</td></tr><tr><td colspan="1" rowspan="1">Baxter et al. <sup><xref ref-type="bibr" rid="CR63">63</xref></sup></td><td colspan="1" rowspan="1">Postsurgical Opioid Use</td><td colspan="1" rowspan="1">EHRs</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">LR, GB, XGBOOST</td><td colspan="1" rowspan="1">GBM / Logistic Regression</td><td colspan="1" rowspan="1">(0.84)</td><td colspan="1" rowspan="1">Not performed</td></tr><tr><td colspan="1" rowspan="1">Gabriel et al. <sup><xref ref-type="bibr" rid="CR33">33</xref></sup></td><td colspan="1" rowspan="1">Postsurgical Opioid Use</td><td colspan="1" rowspan="1">EHRs</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">6 models (LR, RF, SFNN, BRF, BBC, SVM&#8201;+&#8201;SMOTE)</td><td colspan="1" rowspan="1">RFClassifier</td><td colspan="1" rowspan="1">AUC. 94 and. 96 with SMOTE</td><td colspan="1" rowspan="1">Brier Score</td></tr><tr><td colspan="1" rowspan="1">Giladi et al. <sup><xref ref-type="bibr" rid="CR62">62</xref></sup></td><td colspan="1" rowspan="1">Postsurgical Opioid Use</td><td colspan="1" rowspan="1">EHRs</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">LR, RF, XGBoost</td><td colspan="1" rowspan="1">XGBOOST</td><td colspan="1" rowspan="1">XGBOOST (0.72)</td><td colspan="1" rowspan="1">Calibration plots &amp; Brier Score</td></tr><tr><td colspan="1" rowspan="1">Grazal et al. <sup><xref ref-type="bibr" rid="CR46">46</xref></sup></td><td colspan="1" rowspan="1">Postsurgical Opioid Use</td><td colspan="1" rowspan="1">EHRs &amp; AD</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">6 models (NB, GBM, EGB, RF, ENPLR, ANN)</td><td colspan="1" rowspan="1">Neural Network</td><td colspan="1" rowspan="1">AUC. 71, Brier score. 21</td><td colspan="1" rowspan="1">Calibration plots &amp; Brier Score</td></tr><tr><td colspan="1" rowspan="1">Hur et al. <sup><xref ref-type="bibr" rid="CR28">28</xref></sup></td><td colspan="1" rowspan="1">Postsurgical Opioid Use</td><td colspan="1" rowspan="1">AD</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">Linear models (SVM) against non-linear (ensemble of decision trees)</td><td colspan="1" rowspan="1">XGBoost</td><td colspan="1" rowspan="1">Non-linear (AUC. 68) for refills (AUC. 66 for New persistent use)</td><td colspan="1" rowspan="1">Not performed</td></tr><tr><td colspan="1" rowspan="1">Karhade et al. <sup><xref ref-type="bibr" rid="CR60">60</xref></sup></td><td colspan="1" rowspan="1">Postsurgical Opioid Use</td><td colspan="1" rowspan="1">EHRs</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">5 models (ENPLR, RF, SGB, NN, SVM)</td><td colspan="1" rowspan="1">GBM</td><td colspan="1" rowspan="1">AUC. 81, Brier score. 075</td><td colspan="1" rowspan="1">Calibration plots &amp; Brier Score</td></tr><tr><td colspan="1" rowspan="1">Karhade et al. <sup><xref ref-type="bibr" rid="CR24">24</xref></sup></td><td colspan="1" rowspan="1">Postsurgical Opioid Use</td><td colspan="1" rowspan="1">EHRs</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">5 models (ENPLR, RF, SGB, NN, SVM)</td><td colspan="1" rowspan="1">Neural Network</td><td colspan="1" rowspan="1">AUC. 81, Brier Score. 064</td><td colspan="1" rowspan="1">Calibration plots &amp; Brier Score</td></tr><tr><td colspan="1" rowspan="1">Karhade et al. <sup><xref ref-type="bibr" rid="CR59">59</xref></sup></td><td colspan="1" rowspan="1">Postsurgical Opioid Use</td><td colspan="1" rowspan="1">EHRs</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">5 models (ENPLR, RF, SGB, NN, SVM)</td><td colspan="1" rowspan="1">ENPLR</td><td colspan="1" rowspan="1">ENPLR (AUC. 81, Brier Score. 051)</td><td colspan="1" rowspan="1">Calibration plots &amp; Brier Score</td></tr><tr><td colspan="1" rowspan="1">Karhade et al. <sup><xref ref-type="bibr" rid="CR23">23</xref></sup></td><td colspan="1" rowspan="1">Postsurgical Opioid Use</td><td colspan="1" rowspan="1">EHRs</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">5 models (RF, SGB, NN, SVM, ENPLR)</td><td colspan="1" rowspan="1">ENPLR</td><td colspan="1" rowspan="1">ENPLR (AUC. 70, Brier Score. 039)</td><td colspan="1" rowspan="1">Calibration plots &amp; Brier Score</td></tr><tr><td colspan="1" rowspan="1">Katakam et al. <sup><xref ref-type="bibr" rid="CR32">32</xref></sup></td><td colspan="1" rowspan="1">Postsurgical Opioid Use</td><td colspan="1" rowspan="1">EHRs</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">5 models (SGB, RF, SVM, NN, ENPLR)</td><td colspan="1" rowspan="1">SGB</td><td colspan="1" rowspan="1">SGB (AUC. 76, Brier score. 073)</td><td colspan="1" rowspan="1">Calibration plots &amp; Brier Score</td></tr><tr><td colspan="1" rowspan="1">Klemt et al. <sup><xref ref-type="bibr" rid="CR34">34</xref></sup></td><td colspan="1" rowspan="1">Postsurgical Opioid Use</td><td colspan="1" rowspan="1">EHRs</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">5 models (ANN, SGB, RF, KNN, ENPLR)</td><td colspan="1" rowspan="1">Neural Network</td><td colspan="1" rowspan="1">NN (AUC. 87, Brier score. 036)</td><td colspan="1" rowspan="1">Calibration plots &amp; Brier Score</td></tr><tr><td colspan="1" rowspan="1">Kunze et al. <sup><xref ref-type="bibr" rid="CR45">45</xref></sup></td><td colspan="1" rowspan="1">Postsurgical Opioid Use</td><td colspan="1" rowspan="1">EHRs</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">5 models (SGB, RF, SVM, NN, ENPLR)</td><td colspan="1" rowspan="1">SGB</td><td colspan="1" rowspan="1">SGB (AUC. 75, Brier score. 13)</td><td colspan="1" rowspan="1">Calibration plots &amp; Brier Score</td></tr><tr><td colspan="1" rowspan="1">Lu et al. <sup><xref ref-type="bibr" rid="CR31">31</xref></sup></td><td colspan="1" rowspan="1">Postsurgical Opioid Use</td><td colspan="1" rowspan="1">EHRs</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">5 models (SVM, RF, XGBoost, AdaBoost, ensemble model)</td><td colspan="1" rowspan="1">RF Classifier</td><td colspan="1" rowspan="1">AUC. 74, Brier Score. 12</td><td colspan="1" rowspan="1">Calibration plots &amp; Brier Score</td></tr><tr><td colspan="1" rowspan="1">Zhang et al. <sup><xref ref-type="bibr" rid="CR61">61</xref></sup></td><td colspan="1" rowspan="1">Postsurgical Opioid Use</td><td colspan="1" rowspan="1">AD</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">7 models (FLR, SLR, LASSO), SVM, two tree-based models (RF and SGB), and tCNN)</td><td colspan="1" rowspan="1">Logistic Regression</td><td colspan="1" rowspan="1">LR based models (AUC. 835-.847, Sensitivity 74.9&#8211;76.5%)</td><td colspan="1" rowspan="1">Calibration plots &amp; Brier Score</td></tr><tr><td colspan="1" rowspan="1">Bjarnadottir et al. <sup><xref ref-type="bibr" rid="CR50">50</xref></sup></td><td colspan="1" rowspan="1">Persistent Opioid Use</td><td colspan="1" rowspan="1">EHRs</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">4 models (LR, LASSO, GB, AB)</td><td colspan="1" rowspan="1">Logistic Regression</td><td colspan="1" rowspan="1">LR (AUC 0.873)</td><td colspan="1" rowspan="1">Not performed</td></tr><tr><td colspan="1" rowspan="1">Calcaterra et al. <sup><xref ref-type="bibr" rid="CR25">25</xref></sup></td><td colspan="1" rowspan="1">Persistent Opioid Use</td><td colspan="1" rowspan="1">EHRs &amp; AD</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">(RF, LR, LASSO)</td><td colspan="1" rowspan="1">Logistic Regression</td><td colspan="1" rowspan="1">LR (AUC 0.68)</td><td colspan="1" rowspan="1">Not performed</td></tr><tr><td colspan="1" rowspan="1">Held et al. <sup><xref ref-type="bibr" rid="CR22">22</xref></sup></td><td colspan="1" rowspan="1">Persistent Opioid Use</td><td colspan="1" rowspan="1">AD</td><td colspan="1" rowspan="1">Switzerland</td><td colspan="1" rowspan="1">LR, RF</td><td colspan="1" rowspan="1">Logistic Regression</td><td colspan="1" rowspan="1">LR (0.927)</td><td colspan="1" rowspan="1">Scaled Brier Score</td></tr><tr><td colspan="1" rowspan="1">Johnson et al. <sup><xref ref-type="bibr" rid="CR51">51</xref></sup></td><td colspan="1" rowspan="1">Persistent Opioid Use</td><td colspan="1" rowspan="1">AD</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">6 models (PCA LR, LR, EN, MLP, XGBOOST, XGBOOST validation)</td><td colspan="1" rowspan="1">XGBOOST</td><td colspan="1" rowspan="1">XGBOOST (0.80)</td><td colspan="1" rowspan="1">Evaluated using calibration curves in supplementary file</td></tr><tr><td colspan="1" rowspan="1">Mohl et al. <sup><xref ref-type="bibr" rid="CR52">52</xref></sup></td><td colspan="1" rowspan="1">Persistent Opioid Use</td><td colspan="1" rowspan="1">EHRs</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">4 models (RF, EL, LR, SPVM)</td><td colspan="1" rowspan="1">RF Classifier</td><td colspan="1" rowspan="1">RF (0.76)</td><td colspan="1" rowspan="1">Calibration Plots</td></tr><tr><td colspan="1" rowspan="1">Dong et al. <sup><xref ref-type="bibr" rid="CR35">35</xref></sup></td><td colspan="1" rowspan="1">Overdose</td><td colspan="1" rowspan="1">EHRs</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">RF, DT, LR, DNN, LSTM, ATT</td><td colspan="1" rowspan="1">LSTM</td><td colspan="1" rowspan="1">LSTM (0.8449)</td><td colspan="1" rowspan="1">Not performed</td></tr><tr><td colspan="1" rowspan="1">Dong et al. <sup><xref ref-type="bibr" rid="CR36">36</xref></sup></td><td colspan="1" rowspan="1">Overdose</td><td colspan="1" rowspan="1">EHRs</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">RF, DT, LR, DP</td><td colspan="1" rowspan="1">RF Classifier</td><td colspan="1" rowspan="1">RF (0.95)</td><td colspan="1" rowspan="1">Not performed</td></tr><tr><td colspan="1" rowspan="1">Gellad et al. <sup><xref ref-type="bibr" rid="CR37">37</xref></sup></td><td colspan="1" rowspan="1">Overdose</td><td colspan="1" rowspan="1">EHRs</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">GBM</td><td colspan="1" rowspan="1">GBM</td><td colspan="1" rowspan="1">GBM (0.86)</td><td colspan="1" rowspan="1">Calibration plots &amp; Brier Score</td></tr><tr><td colspan="1" rowspan="1">Lo-Ciganic et al. <sup><xref ref-type="bibr" rid="CR38">38</xref></sup></td><td colspan="1" rowspan="1">Overdose</td><td colspan="1" rowspan="1">AD</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">GBM</td><td colspan="1" rowspan="1">GBM</td><td colspan="1" rowspan="1">GBM (0.85)</td><td colspan="1" rowspan="1">Performed according to the text but further details not provided</td></tr><tr><td colspan="1" rowspan="1">Lo-Ciganic et al. <sup><xref ref-type="bibr" rid="CR26">26</xref></sup></td><td colspan="1" rowspan="1">Overdose</td><td colspan="1" rowspan="1">AD</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">GBM</td><td colspan="1" rowspan="1">GBM</td><td colspan="1" rowspan="1">GBM (0.85)</td><td colspan="1" rowspan="1">Calibration Plots</td></tr><tr><td colspan="1" rowspan="1">Lo-Ciganic et al <sup><xref ref-type="bibr" rid="CR39">39</xref></sup></td><td colspan="1" rowspan="1">Overdose</td><td colspan="1" rowspan="1">AD</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">NN</td><td colspan="1" rowspan="1">Neural Network</td><td colspan="1" rowspan="1">NN (0.91)</td><td colspan="1" rowspan="1">Calibration Plots</td></tr><tr><td colspan="1" rowspan="1">Ripperger et al. <sup><xref ref-type="bibr" rid="CR40">40</xref></sup></td><td colspan="1" rowspan="1">Overdose</td><td colspan="1" rowspan="1">EHRs</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">WL, LASSO, RIDGE, RF</td><td colspan="1" rowspan="1">Ridge</td><td colspan="1" rowspan="1">RIDGE (0.83)</td><td colspan="1" rowspan="1">Calibration plots &amp; Brier Score</td></tr><tr><td colspan="1" rowspan="1">Sun et al. <sup><xref ref-type="bibr" rid="CR41">41</xref></sup></td><td colspan="1" rowspan="1">Overdose</td><td colspan="1" rowspan="1">AD</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">EN, RF, LR</td><td colspan="1" rowspan="1">EN</td><td colspan="1" rowspan="1">EN (0.887)</td><td colspan="1" rowspan="1">Calibration plots &amp; Brier Score</td></tr><tr><td colspan="1" rowspan="1">Annis et al. <sup><xref ref-type="bibr" rid="CR42">42</xref></sup></td><td colspan="1" rowspan="1">Opioid Use Disorder</td><td colspan="1" rowspan="1">EHRs</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">XGBOOST</td><td colspan="1" rowspan="1">GBM</td><td colspan="1" rowspan="1">0.71</td><td colspan="1" rowspan="1">Not performed</td></tr><tr><td colspan="1" rowspan="1">Banks et al. <sup><xref ref-type="bibr" rid="CR43">43</xref></sup></td><td colspan="1" rowspan="1">Opioid Use Disorder</td><td colspan="1" rowspan="1">EHRs</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">LR, RF, DL</td><td colspan="1" rowspan="1">RF Classifier</td><td colspan="1" rowspan="1">RF (0.79)/RF(0.81)</td><td colspan="1" rowspan="1">Not performed</td></tr><tr><td colspan="1" rowspan="1">Dong et al. <sup><xref ref-type="bibr" rid="CR44">44</xref></sup></td><td colspan="1" rowspan="1">Opioid Use Disorder</td><td colspan="1" rowspan="1">EHRs</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">4 models (RG, DT, RF, NN)</td><td colspan="1" rowspan="1">Neural Network</td><td colspan="1" rowspan="1">NN (0.92) DT (0.88)</td><td colspan="1" rowspan="1">Not performed</td></tr><tr><td colspan="1" rowspan="1">Gao, W. et al. <sup><xref ref-type="bibr" rid="CR47">47</xref></sup></td><td colspan="1" rowspan="1">Opioid Use Disorder</td><td colspan="1" rowspan="1">AD</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">5 models (RG, DT, SVM, RF, NN)</td><td colspan="1" rowspan="1">Neural Network</td><td colspan="1" rowspan="1">NN (0.918) RG (0.915)</td><td colspan="1" rowspan="1">Not performed</td></tr><tr><td colspan="1" rowspan="1">Kashyap et al. <sup><xref ref-type="bibr" rid="CR48">48</xref></sup></td><td colspan="1" rowspan="1">Opioid Use Disorder</td><td colspan="1" rowspan="1">EHRs</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">DLM</td><td colspan="1" rowspan="1">Deep Learning Models</td><td colspan="1" rowspan="1">0.94&#8201;&#177;&#8201;0.008</td><td colspan="1" rowspan="1">Calibration plots &amp; Brier Score</td></tr><tr><td colspan="1" rowspan="1">Liu et al. <sup><xref ref-type="bibr" rid="CR20">20</xref></sup></td><td colspan="1" rowspan="1">Opioid Use Disorder</td><td colspan="1" rowspan="1">EHRs</td><td colspan="1" rowspan="1">Canada</td><td colspan="1" rowspan="1">Ensemble model</td><td colspan="1" rowspan="1">Ensemble method</td><td colspan="1" rowspan="1">0.94</td><td colspan="1" rowspan="1">Not performed</td></tr><tr><td colspan="1" rowspan="1">Lo-Ciganic et al. <sup><xref ref-type="bibr" rid="CR49">49</xref></sup></td><td colspan="1" rowspan="1">Opioid Use Disorder</td><td colspan="1" rowspan="1">AD</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">(RG, RF, GB, NN)</td><td colspan="1" rowspan="1">GBM</td><td colspan="1" rowspan="1">GB (0.882) RG(0.880)</td><td colspan="1" rowspan="1">Performed according to the text but further details not provided</td></tr><tr><td colspan="1" rowspan="1">Segal et al. <sup><xref ref-type="bibr" rid="CR29">29</xref></sup></td><td colspan="1" rowspan="1">Opioid Use Disorder</td><td colspan="1" rowspan="1">AD</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">GB</td><td colspan="1" rowspan="1">GBM</td><td colspan="1" rowspan="1">GB (0.959)</td><td colspan="1" rowspan="1">Not performed</td></tr><tr><td colspan="1" rowspan="1">Che et al. <sup><xref ref-type="bibr" rid="CR55">55</xref></sup></td><td colspan="1" rowspan="1">Opioid Dependency</td><td colspan="1" rowspan="1">EHRs</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">LR, SVM, RF, DNN</td><td colspan="1" rowspan="1">Deep Learning Models</td><td colspan="1" rowspan="1">DNN (0.80)</td><td colspan="1" rowspan="1">Not performed</td></tr><tr><td colspan="1" rowspan="1">Ellis et al. <sup><xref ref-type="bibr" rid="CR56">56</xref></sup></td><td colspan="1" rowspan="1">Opioid Dependency</td><td colspan="1" rowspan="1">EHRs</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">RF</td><td colspan="1" rowspan="1">RF Classifier</td><td colspan="1" rowspan="1">RF (Mean 0.863)</td><td colspan="1" rowspan="1">Not performed</td></tr><tr><td colspan="1" rowspan="1">Fouladvand et al. <sup><xref ref-type="bibr" rid="CR27">27</xref></sup></td><td colspan="1" rowspan="1">Multiple Adverse Outcomes</td><td colspan="1" rowspan="1">AD</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">LR, RIDGE, LASSO, ELASTIC NET, RF, XGBOOST, DNN</td><td colspan="1" rowspan="1">RF Classifier</td><td colspan="1" rowspan="1">0.877</td><td colspan="1" rowspan="1">Not performed</td></tr><tr><td colspan="1" rowspan="1">Sharma et al. <sup><xref ref-type="bibr" rid="CR53">53</xref></sup></td><td colspan="1" rowspan="1">Multiple Adverse Outcomes</td><td colspan="1" rowspan="1">AD</td><td colspan="1" rowspan="1">Canada</td><td colspan="1" rowspan="1">XGBOOST</td><td colspan="1" rowspan="1">XGBOOST</td><td colspan="1" rowspan="1">XGBOOST (0.82)</td><td colspan="1" rowspan="1">Calibration plot and Brier Score</td></tr><tr><td colspan="1" rowspan="1">Sharma et al. <sup><xref ref-type="bibr" rid="CR19">19</xref></sup></td><td colspan="1" rowspan="1">Multiple Adverse Outcomes</td><td colspan="1" rowspan="1">AD</td><td colspan="1" rowspan="1">Canada</td><td colspan="1" rowspan="1">(XGBOOST, SVM, NB, LR, NN)</td><td colspan="1" rowspan="1">Logistic Regression</td><td colspan="1" rowspan="1">LR (0.884)</td><td colspan="1" rowspan="1">Calibration Plots</td></tr><tr><td colspan="1" rowspan="1">Vunikili et al. <sup><xref ref-type="bibr" rid="CR54">54</xref></sup></td><td colspan="1" rowspan="1">Multiple Adverse Outcomes</td><td colspan="1" rowspan="1">EHRs</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">LR, XGBOOST</td><td colspan="1" rowspan="1">XGBOOST</td><td colspan="1" rowspan="1">0.83</td><td colspan="1" rowspan="1">Not performed</td></tr><tr><td colspan="1" rowspan="1">Guo et al. <sup><xref ref-type="bibr" rid="CR57">57</xref></sup></td><td colspan="1" rowspan="1">Mortality after Overdose</td><td colspan="1" rowspan="1">AD</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">GBM</td><td colspan="1" rowspan="1">GBM</td><td colspan="1" rowspan="1">GBM (0.71)</td><td colspan="1" rowspan="1">Calibration plots &amp; Brier Score</td></tr></tbody></table><table-wrap-foot><p><italic toggle="yes">EHRs</italic> Electronic Health Records, <italic toggle="yes">SGB</italic> Stochastic Gradient Boosting - A machine learning technique that builds an ensemble of decision trees in a sequential manner, where each tree is trained to correct the errors of the previous one, <italic toggle="yes">BBF</italic> Bayesian Belief Network, <italic toggle="yes">RF</italic> Random Forest - An ensemble learning method that constructs a multitude of decision trees at training time and outputs the mode of the classes (classification) or mean prediction (regression) of the individual trees, <italic toggle="yes">SVM</italic> Support Vector Machine - A supervised learning model that analyses data used for classification and regression analysis, known for its effectiveness in high-dimensional space, <italic toggle="yes">NN</italic> Neural Network - A computational model based on the structure and functions of biological neural networks, used for estimating or approximating functions that can depend on many inputs, <italic toggle="yes">ENPLR</italic> Elastic Net Penalized Logistic Regression - A type of linear regression that incorporates penalties from both L1 (Lasso) and L2 (Ridge) regularization methods, used in cases where there are correlated features, <italic toggle="yes">XGBOOST</italic> eXtreme Gradient Boosting - An efficient and scalable implementation of gradient boosting framework by J. Friedman, <italic toggle="yes">GBM</italic> Gradient Boosting Machine - A machine learning technique for regression and classification problems, builds an ensemble of decision trees sequentially, with each tree correcting the errors of its predecessor, <italic toggle="yes">NB</italic> Naive Bayes - A simple probabilistic classifier based on applying Bayes&#8217; theorem with strong (naive) independence assumptions between the features, <italic toggle="yes">LR</italic> Logistic Regression - A statistical model that in its basic form uses a logistic function to model a binary dependent variable, <italic toggle="yes">RIDGE</italic> Ridge Regression - A method of estimating the coefficients of multiple-regression models in scenarios where independent variables are highly correlated, <italic toggle="yes">LASSO</italic> Least Absolute Shrinkage and Selection Operator - A regression analysis method that performs both variable selection and regularization in order to enhance the prediction accuracy and interpretability, <italic toggle="yes">DNN</italic> Deep Neural Network - An artificial neural network with multiple layers between the input and output layers, which can model complex nonlinear relationships, <italic toggle="yes">DT</italic> Decision Tree - A decision support tool that uses a tree-like graph or model of decisions and their possible consequences, <italic toggle="yes">PCA LR</italic> Principal Component Analysis Logistic Regression - A logistic regression model where principal component analysis is used to reduce the dimensionality of the input features before applying the regression, <italic toggle="yes">ANN</italic> Artificial Neural Network - A computing system vaguely inspired by the biological neural networks that constitute animal brains, consisting of interconnected nodes that process data and learn patterns, <italic toggle="yes">KNN</italic> K-Nearest Neighbours - A non-parametric method used for classification and regression, where the input consists of the k closest training examples in the feature space, <italic toggle="yes">ADABOOST</italic> Adaptive Boosting &#8211; An ensemble method that combines multiple weak learners to create a strong classifier by focusing on correcting errors from previous models, <italic toggle="yes">SMOTE</italic> Synthetic Minority Over-sampling Technique addresses class imbalance in machine learning by generating synthetic data points for the minority class. This technique helps balance class distribution.</p></table-wrap-foot></table-wrap></p><p id="Par6">The reliability of risk predictions (calibration metrics) was not reported for a notable portion of the reviewed studies (<italic toggle="yes">n</italic>&#8201;=&#8201;18, 40.9%). These metrics are essential for evaluating how well the predicted probabilities align with the actual observed outcomes [Table <xref rid="Tab1" ref-type="table">1</xref>].</p></sec><sec id="Sec5"><title>Outcomes of interest of the reviewed studies</title><p id="Par7">Within clinical prediction, diagnostic prediction models are used to estimate the probability of a disease that is already present, while prognostic models aim to assess the risk of future health conditions<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>. The largest category of studies in this review focused on prognostic models for postoperative opioid use, with 15 studies (34%)<sup><xref ref-type="bibr" rid="CR23">23</xref>,<xref ref-type="bibr" rid="CR31">31</xref>&#8211;<xref ref-type="bibr" rid="CR44">44</xref></sup>. The majority of these studies examined hip or knee arthroscopy<sup><xref ref-type="bibr" rid="CR31">31</xref>,<xref ref-type="bibr" rid="CR45">45</xref>,<xref ref-type="bibr" rid="CR46">46</xref></sup> and spine surgery<sup><xref ref-type="bibr" rid="CR32">32</xref>&#8211;<xref ref-type="bibr" rid="CR34">34</xref></sup>. Other primary outcomes of prediction models included opioid overdose prediction (<italic toggle="yes">n</italic>&#8201;=&#8201;8, 18%)<sup><xref ref-type="bibr" rid="CR26">26</xref>,<xref ref-type="bibr" rid="CR35">35</xref>&#8211;<xref ref-type="bibr" rid="CR41">41</xref></sup>, opioid use disorder (<italic toggle="yes">n</italic>&#8201;=&#8201;8, 18%)<sup><xref ref-type="bibr" rid="CR20">20</xref>,<xref ref-type="bibr" rid="CR29">29</xref>,<xref ref-type="bibr" rid="CR42">42</xref>&#8211;<xref ref-type="bibr" rid="CR44">44</xref>,<xref ref-type="bibr" rid="CR47">47</xref>&#8211;<xref ref-type="bibr" rid="CR49">49</xref></sup> and prolonged opioid use (with varying definitions, to be detailed in subsequent sections) (n&#8201;=&#8201;5, 11%)<sup><xref ref-type="bibr" rid="CR22">22</xref>,<xref ref-type="bibr" rid="CR25">25</xref>,<xref ref-type="bibr" rid="CR50">50</xref>&#8211;<xref ref-type="bibr" rid="CR52">52</xref></sup>. Additionally, four studies (7%) utilised a composite outcome that included hospitalisations, emergency department visits, substance abuse and mortality<sup><xref ref-type="bibr" rid="CR19">19</xref>,<xref ref-type="bibr" rid="CR27">27</xref>,<xref ref-type="bibr" rid="CR53">53</xref>,<xref ref-type="bibr" rid="CR54">54</xref></sup>. A smaller subset of studies concentrated on other opioid-related harms as their main outcomes. Specifically, two studies (5%) focused on opioid dependence<sup><xref ref-type="bibr" rid="CR55">55</xref>,<xref ref-type="bibr" rid="CR56">56</xref></sup>, one (<italic toggle="yes">n</italic>&#8201;=&#8201;1, 2%) on mortality<sup><xref ref-type="bibr" rid="CR57">57</xref></sup>, and one on seizure after tramadol overdose (<italic toggle="yes">n</italic>&#8201;=&#8201;1, 2%)<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>.</p><p id="Par8">In the following sections, we provide a detailed explanation of each identified category and an overall summary of the methods, data collection procedures, and statistical analyses used in these studies to examine their research questions. Full summary of included studies, predictor variables (Supplementary Table <xref rid="MOESM1" ref-type="media">2</xref>) and numbers of participants/ outcomes (Supplementary Table <xref rid="MOESM1" ref-type="media">3</xref>) are included in the online supplementary information.</p></sec><sec id="Sec6"><title>Prognostic models to predict opioid use after surgery</title><p id="Par9">Fifteen studies (34%)<sup><xref ref-type="bibr" rid="CR23">23</xref>,<xref ref-type="bibr" rid="CR24">24</xref>,<xref ref-type="bibr" rid="CR28">28</xref>,<xref ref-type="bibr" rid="CR31">31</xref>&#8211;<xref ref-type="bibr" rid="CR34">34</xref></sup><sup>,<xref ref-type="bibr" rid="CR45">45</xref>,<xref ref-type="bibr" rid="CR46">46</xref>,<xref ref-type="bibr" rid="CR58">58</xref>&#8211;<xref ref-type="bibr" rid="CR63">63</xref></sup> were identified with the primary objective of developing a prognostic predictive model using machine learning to address postoperative opioid use.</p><p id="Par10">All eligible studies were conducted within the last four years, with most of the studies developed within 2022 (<italic toggle="yes">n</italic>&#8201;=&#8201;4/15, 27%)<sup><xref ref-type="bibr" rid="CR31">31</xref>,<xref ref-type="bibr" rid="CR33">33</xref>,<xref ref-type="bibr" rid="CR34">34</xref>,<xref ref-type="bibr" rid="CR46">46</xref></sup>, while the earliest studies were from 2019 (<italic toggle="yes">n</italic>&#8201;=&#8201;3/15, 20%)<sup><xref ref-type="bibr" rid="CR24">24</xref></sup><sup>,<xref ref-type="bibr" rid="CR59">59</xref>,<xref ref-type="bibr" rid="CR60">60</xref></sup>. The studies included in this systematic review used various terms to describe their outcomes related to postoperative opioid use, such as &#8220;prolonged,&#8221; &#8220;chronic use&#8221;, &#8220;persistent,&#8221; &#8220;sustained,&#8221; and &#8220;extended&#8221; opioid use. In the absence of a universally agreed definition that can yield different prevalence results<sup><xref ref-type="bibr" rid="CR64">64</xref></sup>, these definitions varied and encompassing different metrics at various time points. Examples include any opioid prescription filled between 90 to 365 days after surgery, continued opioid use beyond a 3-month postoperative period, use extending up to 6 months, continued postoperative opioid use at specific intervals (14 to 20 days, 6 weeks, 3 months, 6 months), filling at least one opioid prescription more than 90 days after surgery, uninterrupted filling of opioid prescriptions for at least 90 to 180 days, and opioid consumption continuing for at least 150 days following surgery.</p><p id="Par11">Datasets and Sampling: Thirteen studies (<italic toggle="yes">n</italic>&#8201;=&#8201;13/15, 87%) used EHRs as the main data source (two from a military data repository), and the remaining used insurance claims (<italic toggle="yes">n</italic>&#8201;=&#8201;2/15, 13%). All the prediction models in these studies were developed with data from patients in the United States, and external validation could only be identified for two of the developed prediction models<sup><xref ref-type="bibr" rid="CR23">23</xref>,<xref ref-type="bibr" rid="CR24">24</xref></sup> (both in Taiwanese cohorts)<sup><xref ref-type="bibr" rid="CR65">65</xref>,<xref ref-type="bibr" rid="CR66">66</xref></sup>. External validation remains to be performed in non-US and non-Taiwanese patient groups for all these developed models.</p><p id="Par12">Sample sizes across the included studies exhibited substantial variation, ranging from 381<sup><xref ref-type="bibr" rid="CR31">31</xref></sup> to 112,898 patients<sup><xref ref-type="bibr" rid="CR28">28</xref></sup> (mean = 13,209.6, median= 5,507). The overall number of outcome events was considerably smaller for most of the studies, with the percentage of outcome incidence ranging from 4%<sup><xref ref-type="bibr" rid="CR23">23</xref></sup> to 41%<sup><xref ref-type="bibr" rid="CR46">46</xref></sup> (mean = 13%, median= 10%). Although data to develop the prediction models was imbalanced (with an outcome frequency of less than 20%) for thirteen studies in this group, only eight studies explicitly acknowledged it and addressed using techniques such as oversampling (<italic toggle="yes">n</italic>&#8201;=&#8201;2/15, 13%)<sup><xref ref-type="bibr" rid="CR31">31</xref></sup><sup>,</sup><sup><xref ref-type="bibr" rid="CR33">33</xref></sup> or by reporting the area under the precision-recall curve (AUPRC) (<italic toggle="yes">n</italic>&#8201;=&#8201;5, 33%)<sup><xref ref-type="bibr" rid="CR23">23</xref>,<xref ref-type="bibr" rid="CR60">60</xref></sup>. AUPRC provides a more informative measure of classifier performance on imbalanced data sets than more common classification metrics such as AUC and accuracy, which can be misleading in such a scenario. Many of these studies only used demographic and preoperative predictors to build their predictive models. (<italic toggle="yes">n</italic>&#8201;=&#8201;8/15, 53%).</p><p id="Par13">When addressing missing data, only eight studies explained how they were handled. Most of them used multiple imputation method with &#8216;missForest&#8217; (<italic toggle="yes">n</italic>&#8201;=&#8201;7/15, 46%), a popular Random Forest (RF)-based missing data imputation package in software. One used the Multivariate Imputation by Chained Equations (MICE) package in R. While only two studies explicitly mentioned how continuous variables were handled<sup><xref ref-type="bibr" rid="CR46">46</xref>,<xref ref-type="bibr" rid="CR58">58</xref></sup>, eight suggested that they were variables were kept as continuous in downstream analysis; for five studies this was left unclear (33%).</p><p id="Par14">Most studies (<italic toggle="yes">n</italic>&#8201;=&#8201;8/15, 53%) that developed prognostic models to predict opioid use after surgery used a group of five algorithms for predictive modelling due to their ability to handle complex data and produce accurate predictions: Stochastic Gradient Boosting, RF, Support Vector Machine, Neural Network, Elastic-net Penalised Logistic Regression. Other studies also incorporated XGBoost (<italic toggle="yes">n</italic>&#8201;=&#8201;4 out of 15, 27%) and LASSO (<italic toggle="yes">n</italic>&#8201;=&#8201;4 out of 15, 27%) algorithms in their analyses. The most common algorithms were RF (<italic toggle="yes">n</italic>&#8201;=&#8201;12/15, 80%) and Elastic-net penalised logistic regression (<italic toggle="yes">n</italic>&#8201;=&#8201;9/15, 60%). Values reported for the area under the receiver operating characteristic curve (AUC) ranged from 0.68<sup><xref ref-type="bibr" rid="CR28">28</xref></sup> to 0.94<sup><xref ref-type="bibr" rid="CR33">33</xref></sup>. Notably, logistic regression, along with its regularized form, Elastic Net, were consistently reported to perform on par to the performance ensemble methods such as random forests and gradient boosting machine algorithms (<italic toggle="yes">n</italic>&#8201;=&#8201;7/15, 46%). Calibration metrics were reported for most of the studies (<italic toggle="yes">n</italic>&#8201;=&#8201;13/15, 87%), which included calibration plots, intercept, slope and Brier Score (ranging from 0.037 to 0.136) for these studies.</p><p id="Par15">Patient subtypes: Most of the research on opioid use after orthopaedic surgery included patients who underwent a specific single surgical procedure, mainly arthroplasty (<italic toggle="yes">n</italic>&#8201;<italic toggle="yes">=</italic>&#8201;3/15, 20%)<sup><xref ref-type="bibr" rid="CR31">31</xref></sup><sup>,</sup><sup><xref ref-type="bibr" rid="CR45">45</xref></sup><sup>,</sup><sup><xref ref-type="bibr" rid="CR46">46</xref></sup> and spine patients (<italic toggle="yes">n</italic>&#8201;=&#8201;3/15, 20%)<sup><xref ref-type="bibr" rid="CR23">23</xref>,<xref ref-type="bibr" rid="CR24">24</xref>,<xref ref-type="bibr" rid="CR61">61</xref></sup>.</p></sec><sec id="Sec7"><title>Prognostic models to predict opioid use disorder</title><p id="Par16">Eight studies were identified<sup><xref ref-type="bibr" rid="CR20">20</xref>,<xref ref-type="bibr" rid="CR29">29</xref>,<xref ref-type="bibr" rid="CR42">42</xref>&#8211;<xref ref-type="bibr" rid="CR44">44</xref>,<xref ref-type="bibr" rid="CR47">47</xref>&#8211;<xref ref-type="bibr" rid="CR49">49</xref></sup>. All, except for one Canadian study<sup><xref ref-type="bibr" rid="CR20">20</xref></sup> used data from the United States. The sample size varied significantly, ranging from 130,120<sup><xref ref-type="bibr" rid="CR29">29</xref></sup> to 5,183,566&#8201;<sup><xref ref-type="bibr" rid="CR44">44</xref></sup> (mean= 1,116,761, median= 361,527) with the percentage of outcome events ranging from 1% to 4% (Mean = 2%, Median=2%). Data in this category of studies were highly imbalanced. Two studies used oversampling techniques to handle classification imbalance<sup><xref ref-type="bibr" rid="CR20">20</xref>,<xref ref-type="bibr" rid="CR42">42</xref></sup> and three more reported AUPRC<sup><xref ref-type="bibr" rid="CR44">44</xref>,<xref ref-type="bibr" rid="CR47">47</xref>,<xref ref-type="bibr" rid="CR48">48</xref></sup>. No external validation was identified for any of these models. Data-driven variable selection was only mentioned in two studies, using the Andersen Behavioural Model<sup><xref ref-type="bibr" rid="CR42">42</xref></sup> and LASSO logistic regression methods alongside to supervised machine learning algorithms<sup><xref ref-type="bibr" rid="CR44">44</xref></sup>. In terms of performance, Gradient Boosting and neural network classifiers had the best performance based on AUC ranging from 0.88<sup><xref ref-type="bibr" rid="CR49">49</xref></sup> to 0.959<sup><xref ref-type="bibr" rid="CR29">29</xref></sup> with no overall performance benefit over logistic regression. In contrast, Support Vector Machine (SVM) was the worst-performing algorithm<sup><xref ref-type="bibr" rid="CR47">47</xref></sup>. Very few studies (<italic toggle="yes">n</italic>&#8201;=&#8201;2/8, 25%) reported performing calibration as part of their analysis but only one study appropriately reported it, including calibration plots, intercept, slope, and Brier Score<sup><xref ref-type="bibr" rid="CR49">49</xref></sup>.</p></sec><sec id="Sec8"><title>Prognostic models to predict opioid overdose</title><p id="Par17">Eight studies were identified<sup><xref ref-type="bibr" rid="CR26">26</xref>,<xref ref-type="bibr" rid="CR35">35</xref>&#8211;<xref ref-type="bibr" rid="CR41">41</xref></sup>. All the studies in this subgroup were conducted in the United States, four (<italic toggle="yes">n</italic>&#8201;=&#8201;4 out of 8, 50%) used EHR and four used administrative and insurance claims data from sources like Medicaid or Medicare (<italic toggle="yes">n</italic>&#8201;=&#8201;4 out of 8, 50%), with the majority being developed in 2021 (<italic toggle="yes">n</italic>&#8201;=&#8201;3 out of 8, 38%). The population sample size in these studies ranged from 237,259 to 7,284,389, with the percentage of outcome events ranging from 0.04%<sup><xref ref-type="bibr" rid="CR37">37</xref></sup> to 1.36%<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>. Although data imbalance was only directly addressed with imbalance data techniques for three studies<sup><xref ref-type="bibr" rid="CR36">36</xref>,<xref ref-type="bibr" rid="CR37">37</xref>,<xref ref-type="bibr" rid="CR40">40</xref></sup> it was acknowledged by all studies and additional performance metrics were reported, including AUPRC<sup><xref ref-type="bibr" rid="CR26">26</xref></sup><sup>,<xref ref-type="bibr" rid="CR38">38</xref>,<xref ref-type="bibr" rid="CR39">39</xref></sup>. Only one study was externally validated<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>. The models developed in this category had high c-statistics, ranging from 0.85<sup><xref ref-type="bibr" rid="CR26">26</xref></sup> to 0.95<sup><xref ref-type="bibr" rid="CR35">35</xref></sup> and good prediction performance.</p></sec><sec id="Sec9"><title>Prediction models for persistent opioid use</title><p id="Par18">Five studies were identified.<sup><xref ref-type="bibr" rid="CR22">22</xref></sup><sup>,<xref ref-type="bibr" rid="CR25">25</xref>,<xref ref-type="bibr" rid="CR50">50</xref>&#8211;<xref ref-type="bibr" rid="CR52">52</xref></sup> This included three with an explicit chronic opioid use outcome, one focusing on long-term opioid use prediction and one predicting progression from acute to chronic opioid use<sup><xref ref-type="bibr" rid="CR51">51</xref></sup>. All of them were retrospective studies, with the oldest dating back to 2018<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>. The population sample size ranged from 27,705 to 418,564 patients, with the percentage of outcome events ranging from 5%<sup><xref ref-type="bibr" rid="CR25">25</xref></sup> to 30%<sup><xref ref-type="bibr" rid="CR51">51</xref></sup>. Only one study addressed class imbalance but used a down-sampling approach<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>, which risks discarding valuable information potentially leading to reduced model accuracy. All studies had internal validation, but only one was externally validated using data from two additional healthcare organizations<sup><xref ref-type="bibr" rid="CR25">25</xref></sup> (Supplementary Table <xref rid="MOESM1" ref-type="media">4</xref>). The top-performing algorithms in terms of AUC were logistic regression (3 out of 5, 60%)<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>, RF classifier (<italic toggle="yes">n</italic>&#8201;=&#8201;1 out of 5, 20%)<sup><xref ref-type="bibr" rid="CR52">52</xref></sup>, and XGBoost (<italic toggle="yes">n</italic>&#8201;=&#8201;1 out of 5, 20%)<sup><xref ref-type="bibr" rid="CR51">51</xref></sup>, with SVM being the worst performing (AUC&#8201;=&#8201;0.72)<sup><xref ref-type="bibr" rid="CR51">51</xref></sup>. One study also found that class balancing did not have a significant impact on model performance for most models, despite the relatively rare outcome<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>. Only one study in this category (<italic toggle="yes">n</italic>&#8201;=&#8201;1/5, 20%) reported and provided details of calibration for their analysed models<sup><xref ref-type="bibr" rid="CR52">52</xref></sup>. Calibration details reported across studies are presented in Supplementary Table <xref rid="MOESM1" ref-type="media">5</xref>.</p></sec><sec id="Sec10"><title>Prediction models for opioid dependence</title><p id="Par19">Two studies were identified<sup><xref ref-type="bibr" rid="CR55">55</xref>,<xref ref-type="bibr" rid="CR56">56</xref></sup>. The sample size ranged from 102,166 to 199,273. The percentage of outcome events ranged from 0.7%<sup><xref ref-type="bibr" rid="CR55">55</xref></sup> to 3.9%<sup><xref ref-type="bibr" rid="CR56">56</xref></sup>. While both studies used large samples from US EHRs, Che et al benefited from having data from multiple hospitals. Additionally, Che et al. had access to a clear diagnosis of &#8220;opioid dependence&#8221; in the patient records<sup><xref ref-type="bibr" rid="CR55">55</xref></sup> whilst Ellis et al. had to rely on various forms of substance dependence for the definition of their outcome (not exclusive to opioids)<sup><xref ref-type="bibr" rid="CR56">56</xref></sup>. Both studies addressed the small number of outcomes with class imbalance techniques and showed a good discrimination performance of 0.8<sup><xref ref-type="bibr" rid="CR55">55</xref></sup> and 0.87<sup><xref ref-type="bibr" rid="CR56">56</xref></sup>. Che et al. reported that deep learning solutions achieved superior classification results and outperformed other baseline methods. None of the studies reported calibration measures nor were found to be externally validated.</p></sec><sec id="Sec11"><title>Prognostic models to predict other opioid-related harms</title><p id="Par20">Only a limited number of studies investigated opioid-related harms beyond those commonly addressed above. Among these studies, four developed prognostic models using administrative health data sets to predict hospitalization, emergency visits, and mortality<sup><xref ref-type="bibr" rid="CR19">19</xref>,<xref ref-type="bibr" rid="CR27">27</xref>,<xref ref-type="bibr" rid="CR53">53</xref>,<xref ref-type="bibr" rid="CR54">54</xref></sup>. For one of these studies, simpler linear models carried higher discrimination and performance<sup><xref ref-type="bibr" rid="CR19">19</xref></sup> and for another, although the final model using XGBOOST had high discrimination performance, the calibration plot showed a consistent overestimation of risk<sup><xref ref-type="bibr" rid="CR53">53</xref></sup>. Vunikili et al. used a retrospective cohort of patients to build a model predicting opioid abuse and mortality. The XGBoost algorithm outperformed logistic regression for classifying patients susceptible to &#8220;opioid risks&#8221;<sup><xref ref-type="bibr" rid="CR54">54</xref></sup>. Fouladvand, et al. focused on predicting whether a person experienced opioid abuse, dependence, or an overdose event (opioid-related adverse outcomes) during the 6-month period after surgery. The best predictive performance was achieved by the RF model, with an AUC of 0.87. The model was well calibrated and had good discrimination and was externally validated using data from other states within the United States<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>. Other studies in this category developed models to predict mortality risk after nonfatal opioid overdose (using gradient boosting machines)<sup><xref ref-type="bibr" rid="CR57">57</xref></sup> and predict seizure due to tramadol poisoning (using machine learning models that did not show significant performance improvements compared to the logistic regression model)<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>.</p></sec><sec id="Sec12"><title>Risks of bias</title><p id="Par21">In accordance with the Prediction Model Risk of Bias Assessment Tool (PROBAST) guidance, we systematically evaluated the risk of bias in 44 identified studies across four key domains: participants, predictors, outcomes, and analysis (Table <xref rid="Tab2" ref-type="table">2</xref>). We found that 16/44 studies had a high risk of bias in at least one domain and 19/44 unclear in at least one domain due to lack of information. Only 9/44 studies were found to have a low risk of bias across all domains. A summary of the risk of bias assessment for machine learning algorithms grouped by type of outcome is presented in Supplementary Figs. <xref rid="MOESM1" ref-type="media">1</xref>&#8211;<xref rid="MOESM1" ref-type="media">4</xref>.<table-wrap id="Tab2" position="float" orientation="portrait"><label>Table 2</label><caption><p>PROBAST results for each domain considered for each paper included in the systematic review</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="d33e2063" orientation="portrait" xlink:href="41746_2024_1312_Tab1_HTML.jpg"/><table-wrap-foot><p>Risk of bias and applicability were assessed for each study using the Prediction model study Risk of Bias Assessment (PROBAST) tool. The assessment involves scoring each domain as having low (+), high (-) or unclear risk of bias (?) based on predefined criteria<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>.</p></table-wrap-foot></table-wrap></p><p id="Par22">Participants: Ten studies had a high (9/44) or unclear (1/44) risk of bias for their participants. This was primarily due to the following issues: (1) the model was built using datasets from a single health centre (2) the paper&#8217;s inclusion and exclusion criteria is not described with enough details to be reproducible and/or (3) there are large differences in demographics of the target population and the population the data on which the model was built upon.</p><p id="Par23">Predictors: Among the studies, 5/44 lacked sufficient information on predictors, rendering bias assessment challenging. For 36 studies, the risk of bias was deemed low due to the comprehensive description of predictor definition, selection, assessment, and handling during analysis. Conversely, 3/44 studies exhibited a high risk of bias, primarily due to insufficient details for the reproducibility of the analysis.</p><p id="Par24">Outcomes: In terms of outcome variables, 36/44 studies demonstrated low risk, 3/44 were unclear, and 5/44 exhibited a high risk of bias. The key contributing factor was the inconsistency between the studies&#8217; stated objective of predicting opioid-related harms and the inclusion of outcomes not specific to opioid-related harms.</p><p id="Par25">Analysis: Only 11/44 studies were evaluated to have a low risk of bias in their analysis, either by adhering to TRIPOD guidelines, following the Guidelines for Developing and Reporting Machine Learning Models in Biomedical research, or providing sufficient detail on the analysis methodology. Conversely, 28 studies lacked adequate information, leading to classification as unclear risk, while 5 studies exhibited a high risk of bias. Common shortcomings included inadequate information for reproducibility, such as missing data handling, class imbalance handling, hyperparameter description, tool/library versions, and non-availability of code (Table <xref rid="Tab3" ref-type="table">3</xref>).<table-wrap id="Tab3" position="float" orientation="portrait"><label>Table 3</label><caption><p>Description of Studies describing class imbalance considerations hyperparameters and data/ code availability</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">Author</th><th colspan="1" rowspan="1">Year</th><th colspan="1" rowspan="1">Class imbalance considered</th><th colspan="1" rowspan="1">Hyperparameters described</th><th colspan="1" rowspan="1">Version of tools and libraries used</th><th colspan="1" rowspan="1">Dataset available</th><th colspan="1" rowspan="1">Code available</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">Anderson et al.</td><td colspan="1" rowspan="1">2020</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Partial</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">No</td></tr><tr><td colspan="1" rowspan="1">Annis et al.</td><td colspan="1" rowspan="1">2022</td><td colspan="1" rowspan="1">SMOTE and oversampling</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">No</td></tr><tr><td colspan="1" rowspan="1">Banks et al.</td><td colspan="1" rowspan="1">2023</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">On request</td><td colspan="1" rowspan="1">On request</td></tr><tr><td colspan="1" rowspan="1">Baxter et al.</td><td colspan="1" rowspan="1">2023</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">Partial</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Unclear</td></tr><tr><td colspan="1" rowspan="1">Behnoush et al.</td><td colspan="1" rowspan="1">2021</td><td colspan="1" rowspan="1">Not an imbalanced outcome</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">Partial</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">No</td></tr><tr><td colspan="1" rowspan="1">Bjarnadottir et al.</td><td colspan="1" rowspan="1">2022</td><td colspan="1" rowspan="1">Stratified bootstrapping</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">On request</td></tr><tr><td colspan="1" rowspan="1">Calcaterra et al.</td><td colspan="1" rowspan="1">2018</td><td colspan="1" rowspan="1">Down-sampling</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">No</td></tr><tr><td colspan="1" rowspan="1">Che et al.</td><td colspan="1" rowspan="1">2017</td><td colspan="1" rowspan="1">Down-sampling</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">Partial</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">No</td></tr><tr><td colspan="1" rowspan="1">Dong et al.<sup><xref ref-type="bibr" rid="CR44">44</xref></sup></td><td colspan="1" rowspan="1">2021</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">Not mentioned, but hyper-parameter tuning suggested</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Yes</td></tr><tr><td colspan="1" rowspan="1">Dong et al.<sup><xref ref-type="bibr" rid="CR35">35</xref></sup></td><td colspan="1" rowspan="1">2021</td><td colspan="1" rowspan="1">Not balanced</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Yes</td></tr><tr><td colspan="1" rowspan="1">Dong et al.</td><td colspan="1" rowspan="1">2019</td><td colspan="1" rowspan="1">Under sampling</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">No</td></tr><tr><td colspan="1" rowspan="1">Ellis et al.</td><td colspan="1" rowspan="1">2019</td><td colspan="1" rowspan="1">Over sampling</td><td colspan="1" rowspan="1">Partial</td><td colspan="1" rowspan="1">Partial</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">No</td></tr><tr><td colspan="1" rowspan="1">Fouladvand et al.</td><td colspan="1" rowspan="1">2023</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">No</td></tr><tr><td colspan="1" rowspan="1">Gabriel et al.</td><td colspan="1" rowspan="1">2022</td><td colspan="1" rowspan="1">Oversampling</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">On request</td><td colspan="1" rowspan="1">Unclear</td></tr><tr><td colspan="1" rowspan="1">Gao, W. et al.</td><td colspan="1" rowspan="1">2021</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">No</td></tr><tr><td colspan="1" rowspan="1">Gellad et al.</td><td colspan="1" rowspan="1">2023</td><td colspan="1" rowspan="1">Down-sampling</td><td colspan="1" rowspan="1">Partial</td><td colspan="1" rowspan="1">Partial</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">No</td></tr><tr><td colspan="1" rowspan="1">Giladi et al.</td><td colspan="1" rowspan="1">2023</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">No</td></tr><tr><td colspan="1" rowspan="1">Grazal et al.</td><td colspan="1" rowspan="1">2022</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">Partial</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Yes</td></tr><tr><td colspan="1" rowspan="1">Guo et al.</td><td colspan="1" rowspan="1">2021</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">No</td></tr><tr><td colspan="1" rowspan="1">Held et al.</td><td colspan="1" rowspan="1">2023</td><td colspan="1" rowspan="1">To control imbalance a second RF model was fitted on stratified random samples.</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">On request</td><td colspan="1" rowspan="1">On request</td></tr><tr><td colspan="1" rowspan="1">Hur et al.</td><td colspan="1" rowspan="1">2021</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Yes</td></tr><tr><td colspan="1" rowspan="1">Johnson et al.</td><td colspan="1" rowspan="1">2022</td><td colspan="1" rowspan="1">Not mentioned but AUPRC provided</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Yes</td></tr><tr><td colspan="1" rowspan="1">Karhade et al.</td><td colspan="1" rowspan="1">2020</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">Partial</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Mentioned but not accessible (an error occurs).</td></tr><tr><td colspan="1" rowspan="1">Karhade et al.,<sup><xref ref-type="bibr" rid="CR60">60</xref></sup></td><td colspan="1" rowspan="1">2019</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">Partial</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">No</td></tr><tr><td colspan="1" rowspan="1">Karhade et al.,<sup><xref ref-type="bibr" rid="CR24">24</xref></sup></td><td colspan="1" rowspan="1">2019</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">Partial</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">No</td></tr><tr><td colspan="1" rowspan="1">Karhade et al.,<sup><xref ref-type="bibr" rid="CR59">59</xref></sup></td><td colspan="1" rowspan="1">2019</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">Partial</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">No</td></tr><tr><td colspan="1" rowspan="1">Kashyap et al</td><td colspan="1" rowspan="1">2023</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">Partial</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">No</td></tr><tr><td colspan="1" rowspan="1">Katakam et al.</td><td colspan="1" rowspan="1">2020</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">Partial</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">No</td></tr><tr><td colspan="1" rowspan="1">Klemt et al.</td><td colspan="1" rowspan="1">2022</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">Partial</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">No</td></tr><tr><td colspan="1" rowspan="1">Kunze et al.</td><td colspan="1" rowspan="1">2021</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">Partial</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">No</td></tr><tr><td colspan="1" rowspan="1">Liu et al.</td><td colspan="1" rowspan="1">2023</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Partial</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">No</td></tr><tr><td colspan="1" rowspan="1">Lo-Ciganic et al.</td><td colspan="1" rowspan="1">2021</td><td colspan="1" rowspan="1">Not mentioned, but AUPRC reported</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">On request</td><td colspan="1" rowspan="1">On request</td></tr><tr><td colspan="1" rowspan="1">Lo-Ciganic et al.,</td><td colspan="1" rowspan="1">2022</td><td colspan="1" rowspan="1">Not mentioned, but they used different measure to evaluate model performance.</td><td colspan="1" rowspan="1">Not mentioned, but hyper-parameter tuning suggested</td><td colspan="1" rowspan="1">Partial</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">No</td></tr><tr><td colspan="1" rowspan="1">Lo-Ciganic et al.,</td><td colspan="1" rowspan="1">2020</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">Not mentioned, but hyper-parameter tuning suggested</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">On request</td><td colspan="1" rowspan="1">No</td></tr><tr><td colspan="1" rowspan="1">Lo-Ciganic et al.,</td><td colspan="1" rowspan="1">2019</td><td colspan="1" rowspan="1">Not mentioned, but AUPRC reported</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">Partial</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">No</td></tr><tr><td colspan="1" rowspan="1">Lu et al.</td><td colspan="1" rowspan="1">2022</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">Partial</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">No</td></tr><tr><td colspan="1" rowspan="1">Mohl et al</td><td colspan="1" rowspan="1">2023</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">No</td></tr><tr><td colspan="1" rowspan="1">Ripperger et al.</td><td colspan="1" rowspan="1">2021</td><td colspan="1" rowspan="1">Under-sampling</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">No</td></tr><tr><td colspan="1" rowspan="1">Segal et al.</td><td colspan="1" rowspan="1">2020</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Partial</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">No</td></tr><tr><td colspan="1" rowspan="1">Sharma et al.</td><td colspan="1" rowspan="1">2022</td><td colspan="1" rowspan="1">Weight scaling</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">No</td></tr><tr><td colspan="1" rowspan="1">Sharma et al.</td><td colspan="1" rowspan="1">2021</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">No</td></tr><tr><td colspan="1" rowspan="1">Sun et al.</td><td colspan="1" rowspan="1">2020</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">Not mentioned, but hyper-parameter tuning suggested</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">No</td></tr><tr><td colspan="1" rowspan="1">Vunikili et al.</td><td colspan="1" rowspan="1">2021</td><td colspan="1" rowspan="1">Oversampling</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">No</td></tr><tr><td colspan="1" rowspan="1">Zhang et al.</td><td colspan="1" rowspan="1">2020</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Mentioned but not accessible (an error occurs).</td></tr></tbody></table><table-wrap-foot><p><italic toggle="yes">AUPRC</italic> area under the precision-recall curve, <italic toggle="yes">SMOTE</italic> Synthetic Minority Over-sampling Technique.</p></table-wrap-foot></table-wrap></p><p id="Par26">Public availability of the algorithms and models: Only 5/44 studies published the code for reproducing their results, 4/44 suggested that it is available on request (Table <xref rid="Tab3" ref-type="table">3</xref>).</p></sec></sec><sec id="Sec13" sec-type="discussion"><title>Discussion</title><p id="Par27">This systematic review summarises the extensive efforts of the international community to address the opioid crisis by developing ML prediction models. Comparing complex models with more interpretable ones is necessary to assess whether the trade-offs between performance and interpretability is justified<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>. Studies in this area have primarily been published in recent years and show promise and potential in identifying patients at risk of opioid-related harms in North America (<italic toggle="yes">n</italic>&#8201;=&#8201;36/44, including studies from the US <italic toggle="yes">n</italic>&#8201;=&#8201;33/44 and Canada <italic toggle="yes">n</italic>&#8201;=&#8201;3/44). However, our findings reveal specific methodological limitations, including poor transparency, inadequate machine learning methodology disclosure, limited reproducibility, and biases in study design. The existing literature often relies on C-statistics alone as a performance metric, which may lead to overestimating the advantages of the prediction tools for rare outcomes. In a highly imbalanced dataset, as can be the case with opioid-adverse events, the ROC curve can be overly optimistic. ROC-AUC performance metric is calculated based on the true positive rate and false positive rate<sup><xref ref-type="bibr" rid="CR67">67</xref></sup>. The true positive rate (also known as sensitivity or recall) represents the proportion of actual positives correctly identified as such. The false positive rate represents the proportion of actual negatives incorrectly identified as positives<sup><xref ref-type="bibr" rid="CR68">68</xref></sup>. When the true negative rate is much larger (also known as the specificity or calculated as 1- false positive rate), even a large number of false positives might result in a low false positive rate, artificially inflating the AUC and giving a false impression of high performance (AUC close to 1) even when the model is not effectively identifying the few positive cases. Considering additional metrics, such as the Precision-Recall curve, F1 Score, or other metrics could better reflect model performance in imbalanced scenarios<sup><xref ref-type="bibr" rid="CR69">69</xref></sup>. The absence of calibration reporting in a substantial proportion of the examined studies (41%) raised concerns about the reliability of the reviewed prediction models. Details about internal and external validation for each of the studies is included in Supplementary Table <xref rid="MOESM1" ref-type="media">4</xref>.</p><p id="Par28">Our review suggests that developed ML models for predicting opioid related harms primarily showcase ML&#8217;s potential rather than being created for clinical application, making them restricted for research purposes only. Key barriers to the practical application of these prediction models include the lack of external validation, accessibility, and the infrastructure to process risk scores and to ensure the algorithms usability and effectiveness<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>. Given the importance of model interpretability for government policymaking, we suggest using explanatory algorithms such as Local Interpretable Model-Agnostic Explanations (LIME)<sup><xref ref-type="bibr" rid="CR70">70</xref></sup> and Shapley Additive Explanations (SHAP)<sup><xref ref-type="bibr" rid="CR71">71</xref></sup>. Explanatory algorithms could allow clinicians and patients to understand the relationships between the variables in the model, making them more transparent and interpretable. In the reviewed studies only 36% (<italic toggle="yes">n</italic>&#8201;=&#8201;16/44) included them in their analysis. However, these methods have limitations. Both LIME and SHAP provide insights based on the correlations defined by the model, but they do not offer causal explanations. Additionally, these methods may struggle with collinearity; for example, in the presence of highly correlated variables, SHAP values might be high for one variable and zero or very low for another<sup><xref ref-type="bibr" rid="CR72">72</xref></sup>. Furthermore, calculating SHAP values can be computationally expensive, especially for large datasets or complex models. Lastly, the SHAP method assumes the model is a &#8220;black box&#8221;, meaning it does not incorporate information about the model&#8217;s internal structure<sup><xref ref-type="bibr" rid="CR73">73</xref></sup>.</p><p id="Par29">Only five models reached the threshold of methodological quality, reproducibility, and external validation that is required to support utilization in clinical practice. For most studies (<italic toggle="yes">n</italic>&#8201;=&#8201;39,89%) there was an absence of reporting on how results could be implemented clinically or for external validation. This limitation emphasises why deployment of ML models in real-world clinical settings remains uncommon<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>. The generalisability of the reviewed models is also limited, due to the use of data from limited sources such as being from a single centre,<sup><xref ref-type="bibr" rid="CR21">21</xref></sup><sup>,<xref ref-type="bibr" rid="CR62">62</xref>,<xref ref-type="bibr" rid="CR63">63</xref></sup> a single geographic area,<sup><xref ref-type="bibr" rid="CR26">26</xref></sup> or sources that don&#8217;t fully reflect the population they aim to study<sup><xref ref-type="bibr" rid="CR58">58</xref></sup>.</p><p id="Par30">Sampling bias in data collection was found to be a common problem in studies using insurance claims datasets (which don&#8217;t fully capture the demographics most at risk for opioid-related harms) and research based on military personnel data (which may focus on a younger, predominantly male population<sup><xref ref-type="bibr" rid="CR58">58</xref></sup>). Some studies (<italic toggle="yes">n</italic>&#8201;=&#8201;4,9%) also revealed risk of racial bias and found differences in the racial composition of the groups used to develop the model versus those used to test it<sup><xref ref-type="bibr" rid="CR62">62</xref></sup>, which could particularly impact under-represented subgroups of patients and are important considerations in the development of ML algorithms<sup><xref ref-type="bibr" rid="CR74">74</xref></sup>.</p><p id="Par31">Predictor variables varied significantly across the studies that developed clinical prediction models, with various studies not providing a complete list of variables used, which raises concerns about reproducibility. While demographic factors such as age and sex were commonly reported, only 15 out of 44 studies (<italic toggle="yes">n</italic>&#8201;=&#8201;34%) explicitly included socioeconomic status as a predictor in their models. The lack of consistent reporting and inclusion of variables such as socioeconomic status in many studies may weaken the robustness of the ML models and limit their generalisability.</p><p id="Par32">For the identified models aimed to predict mortality, their accuracy is questionable since the cause of death was not always available and may not necessarily be related to opioid exposure<sup><xref ref-type="bibr" rid="CR57">57</xref></sup>.</p><p id="Par33">For the selection of model predictors, authors chose them based on theory or previous literature. There is an opportunity to explore the benefits of a pure data mining approach and compare its utility against with models developed with user input<sup><xref ref-type="bibr" rid="CR43">43</xref></sup>. The addition of opioid dosage (e.g. as morphine milligram equivalents per day) in future prediction models aimed for clinical implementation is crucial. Even though opioid dose has been found to be associated with a higher likelihood of opioid-harms by several studies<sup><xref ref-type="bibr" rid="CR43">43</xref>,<xref ref-type="bibr" rid="CR75">75</xref></sup>, less than half of the reviewed studies (<italic toggle="yes">n</italic>&#8201;=&#8201;21,44%) considered opioid dosage, often due to lack of data availability. Additionally, considering the time-varying nature of opioid use with discrete periods of being on or off the drug, transparent preparation of this type of data is especially important to avoid misclassification of opioid exposure that can considerably affect the point estimates associated with adverse outcomes<sup><xref ref-type="bibr" rid="CR76">76</xref></sup>. None of the reviewed models that predicted adverse opioid outcomes employed ML for time-to-event analysis, indicating a potential area for future development.</p><p id="Par34">Recent advancements in deep learning have shown strong predictive capabilities of transformer-based models, which could improve the performance of existing ML models in fields like healthcare<sup><xref ref-type="bibr" rid="CR77">77</xref></sup>. Originally developed for natural language processing, their ability to capture structure in human language could generalise to life-sequences, such as socio-economic and health data, for classification tasks. However, despite their ability to provide highly accurate predictions and often outperform state-of-the-art algorithms, transformer-based models are still nascent in the context of clinical prediction modelling and present several current challenges. These include their highly complex architectures with multiple layers of attention mechanisms, a vast number of parameters, high computational demands, domain-specific adaptations and the need for large, high-quality, well-curated datasets<sup><xref ref-type="bibr" rid="CR78">78</xref></sup>.</p><p id="Par35">We would like to acknowledge strengths and limitations of the current study. This review evaluated and summarised systematically the various applications of machine learning models in addressing prescription opioid-related harms in adults. We acknowledge that some authors may have performed model calibration as well as handling class imbalance and missing data but not mentioned so in their studies. Therefore, we labelled risk of bias as &#8220;unclear&#8221; to avoid overestimating problems. In cases with not enough information on model development, performance, and calibration, it is hard to interpret the validity of the results. This study complements the works by Garbin et al. and Emam et al., by focusing specifically on machine learning-based prognostic models that predict opioid-related harms and assessing bias risk using PROBAST. Systematic reviews have been partially conducted addressing the opioid epidemic in the present year<sup><xref ref-type="bibr" rid="CR79">79</xref>,<xref ref-type="bibr" rid="CR80">80</xref></sup>, mainly focusing on postoperative opioid misuse, while other opioid-related harms have not undergone similar assessments. In addition, we report on specific areas of development that could be useful for future research building on the work done in this field thus far.</p><p id="Par36">The application of machine learning in predicting opioid-related harms and identifying at-risk patients has shown promising results, offering valuable insights into the complex landscape of opioid use. Currently, most of these models have not been implemented in clinical practice. Instead, they serve as research tools, illustrating the potential power of machine learning in enhancing our understanding of opioid-related harms. One of the key limitations of the current literature is the lack of transparency reporting and limited external validation studies for the developed prediction models using ML. In navigating the future integration of ML in opioid-related harm prediction, researchers should prioritise comprehensive validation efforts, ensuring that these models are robust, generalisable, and properly reported to be reproducible.</p></sec><sec id="Sec14"><title>Methods</title><sec id="Sec15"><title>Identification of studies</title><p id="Par37">To identify relevant articles that were published from the inception of records until the 12th of October 2023, an all-time search was conducted using Ovid MEDLINE, PubMed, and SCOPUS databases. The search was performed without any restrictions on publication date, language, or study design to ensure all relevant studies were included. To improve transparency, we followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist<sup><xref ref-type="bibr" rid="CR81">81</xref></sup>. Using the Population, Intervention, Comparison, and Outcome (PICO) framework, we defined our relevant search: different types of prescription opioids (population), a broad definition of ML (intervention) and opioid-related harms (outcome). We used a combination of MeSH terms, keywords, and Boolean operators to construct our search string (full search details are provided in Supplementary Table <xref rid="MOESM1" ref-type="media">6</xref>).</p></sec><sec id="Sec16"><title>Inclusion criteria</title><p id="Par38">We used a three-stage process to identify the studies to be included in this review (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). Articles were eligible for full-text review if they detailed construction of one or more machine learning-based prediction models, focusing on a primary outcome directly associated with prescription opioid-harms. We specifically sought studies addressing harms such as dependence, misuse, abuse, overdose, hospitalisations, and death. It is important to note that the terminology used to describe these harms varied across studies. Terms such as chronic opioid use, long-term opioid use, and persistent opioid use may have been used interchangeably or with different definitions<sup><xref ref-type="bibr" rid="CR64">64</xref></sup>. Opioid dependence, whilst sometimes used synonymously in the literature, is the adaptation to repeated exposure to some drugs and medicines usually characterised by tolerance and/or withdrawal and may be inevitable for those on long-term opioids<sup><xref ref-type="bibr" rid="CR82">82</xref></sup>. Addiction relates to dependence with a compulsive preoccupation to seek and take an opioid despite consequences<sup><xref ref-type="bibr" rid="CR82">82</xref></sup>. To ensure a comprehensive coverage of opioid-related harms, we included studies that used a range of these terms and their synonyms (Supplementary Table <xref rid="MOESM1" ref-type="media">6</xref>). Regarding methodology, we considered a study to use supervised machine learning if it reported any statistical learning technique to predict outcomes of interest or categorise cases based on a known ground truth, regardless of the terminology used by the authors<sup><xref ref-type="bibr" rid="CR83">83</xref>,<xref ref-type="bibr" rid="CR84">84</xref></sup>. We excluded studies that developed models based solely on regression techniques. In addition, eligible studies had to predominantly utilise data from EHRs or patient administrative records.</p></sec><sec id="Sec17"><title>Exclusion criteria</title><p id="Par39">We excluded studies from our review if they met any of the following criteria: 1) studies that primarily focused on risk factor identification without a clear emphasis on predictive modelling; 2) studies utilising ML to process and analyse human language, enhance the reading of images, to understand user-generated text; 3) studies employing genetic traits or molecular markers as predictive factors; 4) studies that were systematic reviews, letters, conference abstracts or commentaries: 5) studies relying on data sources other than EHRs or administrative patient data (e.g. public domain data such as social media, internet searches, and surveys); 6) studies not concentrating on human subjects or those specifically targeting paediatric populations (patients younger than 18 years old). Full inclusion and exclusion criteria can be found in [Table <xref rid="Tab4" ref-type="table">4</xref>].<table-wrap id="Tab4" position="float" orientation="portrait"><label>Table 4 -</label><caption><p>Eligibility criteria of included studies</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">Parameter</th><th colspan="1" rowspan="1">Inclusion Criteria</th><th colspan="1" rowspan="1">Exclusion Criteria</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">General</td><td colspan="1" rowspan="1">Full-text articles published in any language from inception to October 12th, 2023</td><td colspan="1" rowspan="1">Abstracts, Reviews, Letters</td></tr><tr><td colspan="1" rowspan="1">Participants</td><td colspan="1" rowspan="1">Adult human patients</td><td colspan="1" rowspan="1"><p>Paediatric population</p><p>Non-human subjects</p><p>Patient data from public domain data sets such as social media and surveys</p></td></tr><tr><td colspan="1" rowspan="1">Intervention</td><td colspan="1" rowspan="1">NA</td><td colspan="1" rowspan="1">NA</td></tr><tr><td colspan="1" rowspan="1">Comparator</td><td colspan="1" rowspan="1">ML Algorithms used, performance metrics such as AUPRC, AUC, Accuracy, Precision, Sensibility, Calibration, Brier Score, F1 Score.</td><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Outcome</td><td colspan="1" rowspan="1">Prediction</td><td colspan="1" rowspan="1">- Studies that applied natural language processing (NLP) to understand user-generated text for pharmacovigilance - Validation studies</td></tr><tr><td colspan="1" rowspan="1">Study Design</td><td colspan="1" rowspan="1">Cohort studies</td><td colspan="1" rowspan="1">Commentaries and opinion pieces without primary data</td></tr></tbody></table><table-wrap-foot><p><italic toggle="yes">AUC</italic> area under the curve, <italic toggle="yes">AUPRC</italic> area under the precision-recall curve, <italic toggle="yes">ML</italic> machine learning</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec18"><title>Screening process used to select studies for inclusion</title><p id="Par40">All abstracts were screened by C.R. with uncertainties being resolved by consensus with M.J. The full text of selected abstracts was assessed for eligibility by C.R., with the supervision of M.J.</p></sec><sec id="Sec19"><title>Data extraction, quality assessment and analysis</title><p id="Par41">In our data extraction using the &#8220;CHecklist for critical Appraisal and data extraction for systematic Reviews of prediction Modelling Studies&#8221; (CHARMS) checklist Bias assessment process was performed using the Prediction model Risk of Bias Assessment (PROBAST) tool. We followed the standardised checklist designed by B.M. Fernandez-Felix, et al.<sup><xref ref-type="bibr" rid="CR85">85</xref></sup>. The data collected for each study included information such as study design, sample size, number of outcome events, main data sources, machine learning algorithms used, the best and worst algorithms based on C-statistic, outcomes measured and their definition, mention of class imbalance (imbalance between the frequency of outcome events and nonevents)<sup><xref ref-type="bibr" rid="CR86">86</xref></sup> and missingness, calibration measures reported and details of internal and external validation. The full list of extraction items can be found in the Supplementary Table <xref rid="MOESM1" ref-type="media">6</xref>. To identify external validation studies an all-time search was conducted on October 12, 2023, using Ovid MEDLINE, PubMed, and SCOPUS databases (full search details are provided in Supplementary Table <xref rid="MOESM1" ref-type="media">6</xref>).</p></sec></sec><sec id="Sec20" sec-type="supplementary-material"><title>Supplementary information</title><p>
<supplementary-material content-type="local-data" id="MOESM1" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="41746_2024_1312_MOESM1_ESM.pdf" position="float" orientation="portrait"><caption><p>Supplementary Material</p></caption></media></supplementary-material>
</p></sec></body><back><fn-group><fn><p><bold>Publisher&#8217;s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><sec><title>Supplementary information</title><p>The online version contains supplementary material available at 10.1038/s41746-024-01312-4.</p></sec><ack><title>Acknowledgements</title><p>This work was funded by the National Institute for Health and Care Research (NIHR) [NIHR301413]. M.J. is funded by an NIHR Advanced Fellowship [NIHR301413]. The views expressed in this publication are those of the authors and not necessarily those of the NIHR, NHS or the UK Department of Health and Social Care. The funder played no role in study design, data collection, analysis and interpretation of data, or the writing of this manuscript.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p><italic toggle="yes">Study Design and Execution:</italic> M.J., and C.R. conceptualized the study. C.R, M.J. and D.A.J. collaboratively designed the study workflow. C.R. conducted formal analysis, including identifying eligible studies, performing data collection and assessing quality of the studies. <italic toggle="yes">Writing and Editing:</italic> C.R. drafted the initial manuscript, and M.J., D.A.J., C.R., and J.A. actively participated in review, editing, and finalization. <italic toggle="yes">Supervision:</italic> M.J. provided overall supervision and guidance throughout the research and writing process. All authors read and approved the final version of the manuscript.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in this published article and its supplementary information. All study materials are available from the corresponding author upon reasonable request.</p></notes><notes id="FPar1" notes-type="COI-statement"><title>Competing interests</title><p id="Par42">The authors declare no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Skolnick</surname><given-names>P</given-names></name></person-group><article-title>The Opioid Epidemic: Crisis and Solutions</article-title><source>Annu Rev. Pharm. Toxicol.</source><year>2018</year><volume>58</volume><fpage>143</fpage><lpage>159</lpage><pub-id pub-id-type="doi">10.1146/annurev-pharmtox-010617-052534</pub-id><pub-id pub-id-type="pmid">28968188</pub-id></element-citation><mixed-citation id="mc-CR1" publication-type="journal">Skolnick, P. The Opioid Epidemic: Crisis and Solutions. <italic toggle="yes">Annu Rev. Pharm. Toxicol.</italic><bold>58</bold>, 143&#8211;159 (2018).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1146/annurev-pharmtox-010617-052534</pub-id><pub-id pub-id-type="pmid">28968188</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="other">NIH National Institute on Drug Abuse. Drug Overdose Deaths: Facts and Figures. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://nida.nih.gov/research-topics/trends-statistics/overdose-death-rates">https://nida.nih.gov/research-topics/trends-statistics/overdose-death-rates</ext-link> (2024).</mixed-citation></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Volkow</surname><given-names>ND</given-names></name><name name-style="western"><surname>Blanco</surname><given-names>C</given-names></name></person-group><article-title>The changing opioid crisis: development, challenges and opportunities</article-title><source>Mol. Psychiatry</source><year>2021</year><volume>26</volume><fpage>218</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1038/s41380-020-0661-4</pub-id><pub-id pub-id-type="pmid">32020048</pub-id><pub-id pub-id-type="pmcid">PMC7398847</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">Volkow, N. D. &amp; Blanco, C. The changing opioid crisis: development, challenges and opportunities. <italic toggle="yes">Mol. Psychiatry</italic><bold>26</bold>, 218&#8211;233 (2021).<pub-id pub-id-type="pmid">32020048</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41380-020-0661-4</pub-id><pub-id pub-id-type="pmcid">PMC7398847</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moore</surname><given-names>EM</given-names></name><name name-style="western"><surname>Warshawski</surname><given-names>T</given-names></name><name name-style="western"><surname>Jassemi</surname><given-names>S</given-names></name><name name-style="western"><surname>Charles</surname><given-names>G</given-names></name><name name-style="western"><surname>Vo</surname><given-names>DX</given-names></name></person-group><article-title>Time to act: Early experience suggests stabilization care offers a feasible approach for adolescents after acute life-threatening opioid toxicity</article-title><source>Paediatr. Child Health</source><year>2022</year><volume>27</volume><fpage>260</fpage><lpage>264</lpage><pub-id pub-id-type="doi">10.1093/pch/pxac034</pub-id><pub-id pub-id-type="pmid">36016592</pub-id><pub-id pub-id-type="pmcid">PMC9394634</pub-id></element-citation><mixed-citation id="mc-CR4" publication-type="journal">Moore, E. M., Warshawski, T., Jassemi, S., Charles, G. &amp; Vo, D. X. Time to act: Early experience suggests stabilization care offers a feasible approach for adolescents after acute life-threatening opioid toxicity. <italic toggle="yes">Paediatr. Child Health</italic><bold>27</bold>, 260&#8211;264 (2022).<pub-id pub-id-type="pmid">36016592</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/pch/pxac034</pub-id><pub-id pub-id-type="pmcid">PMC9394634</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gardner</surname><given-names>EA</given-names></name><name name-style="western"><surname>McGrath</surname><given-names>SA</given-names></name><name name-style="western"><surname>Dowling</surname><given-names>D</given-names></name><name name-style="western"><surname>Bai</surname><given-names>D</given-names></name></person-group><article-title>The Opioid Crisis: Prevalence and Markets of Opioids</article-title><source>Forensic Sci. Rev.</source><year>2022</year><volume>34</volume><fpage>43</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">35105535</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Gardner, E. A., McGrath, S. A., Dowling, D. &amp; Bai, D. The Opioid Crisis: Prevalence and Markets of Opioids. <italic toggle="yes">Forensic Sci. Rev.</italic><bold>34</bold>, 43&#8211;70 (2022).<pub-id pub-id-type="pmid">35105535</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alenezi</surname><given-names>A</given-names></name><name name-style="western"><surname>Yahyouche</surname><given-names>A</given-names></name><name name-style="western"><surname>Paudyal</surname><given-names>V</given-names></name></person-group><article-title>Current status of opioid epidemic in the United Kingdom and strategies for treatment optimisation in chronic pain</article-title><source>Int J. Clin. Pharm.</source><year>2021</year><volume>43</volume><fpage>318</fpage><lpage>322</lpage><pub-id pub-id-type="doi">10.1007/s11096-020-01205-y</pub-id><pub-id pub-id-type="pmid">33252724</pub-id><pub-id pub-id-type="pmcid">PMC8079300</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">Alenezi, A., Yahyouche, A. &amp; Paudyal, V. Current status of opioid epidemic in the United Kingdom and strategies for treatment optimisation in chronic pain. <italic toggle="yes">Int J. Clin. Pharm.</italic><bold>43</bold>, 318&#8211;322 (2021).<pub-id pub-id-type="pmid">33252724</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11096-020-01205-y</pub-id><pub-id pub-id-type="pmcid">PMC8079300</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jani</surname><given-names>M</given-names></name><name name-style="western"><surname>Birlie Yimer</surname><given-names>B</given-names></name><name name-style="western"><surname>Sheppard</surname><given-names>T</given-names></name><name name-style="western"><surname>Lunt</surname><given-names>M</given-names></name><name name-style="western"><surname>Dixon</surname><given-names>WG</given-names></name></person-group><article-title>Time trends and prescribing patterns of opioid drugs in UK primary care patients with non-cancer pain: A retrospective cohort study</article-title><source>PLOS Med.</source><year>2020</year><volume>17</volume><fpage>e1003270</fpage><pub-id pub-id-type="doi">10.1371/journal.pmed.1003270</pub-id><pub-id pub-id-type="pmid">33057368</pub-id><pub-id pub-id-type="pmcid">PMC7561110</pub-id></element-citation><mixed-citation id="mc-CR7" publication-type="journal">Jani, M., Birlie Yimer, B., Sheppard, T., Lunt, M. &amp; Dixon, W. G. Time trends and prescribing patterns of opioid drugs in UK primary care patients with non-cancer pain: A retrospective cohort study. <italic toggle="yes">PLOS Med.</italic><bold>17</bold>, e1003270 (2020).<pub-id pub-id-type="pmid">33057368</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pmed.1003270</pub-id><pub-id pub-id-type="pmcid">PMC7561110</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Humphreys</surname><given-names>K</given-names></name><etal/></person-group><article-title>Responding to the opioid crisis in North America and beyond: recommendations of the Stanford-Lancet Commission</article-title><source>Lancet</source><year>2022</year><volume>399</volume><fpage>555</fpage><lpage>604</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(21)02252-2</pub-id><pub-id pub-id-type="pmid">35122753</pub-id><pub-id pub-id-type="pmcid">PMC9261968</pub-id></element-citation><mixed-citation id="mc-CR8" publication-type="journal">Humphreys, K. et al. Responding to the opioid crisis in North America and beyond: recommendations of the Stanford-Lancet Commission. <italic toggle="yes">Lancet</italic><bold>399</bold>, 555&#8211;604 (2022).<pub-id pub-id-type="pmid">35122753</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(21)02252-2</pub-id><pub-id pub-id-type="pmcid">PMC9261968</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roehrs</surname><given-names>A</given-names></name><name name-style="western"><surname>da Costa</surname><given-names>CA</given-names></name><name name-style="western"><surname>Righi</surname><given-names>RD</given-names></name><name name-style="western"><surname>de Oliveira</surname><given-names>KS</given-names></name></person-group><article-title>Personal Health Records: A Systematic Literature Review</article-title><source>J. Med Internet Res</source><year>2017</year><volume>19</volume><fpage>e13</fpage><pub-id pub-id-type="doi">10.2196/jmir.5876</pub-id><pub-id pub-id-type="pmid">28062391</pub-id><pub-id pub-id-type="pmcid">PMC5251169</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Roehrs, A., da Costa, C. A., Righi, R. D. &amp; de Oliveira, K. S. Personal Health Records: A Systematic Literature Review. <italic toggle="yes">J. Med Internet Res</italic><bold>19</bold>, e13 (2017).<pub-id pub-id-type="pmid">28062391</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2196/jmir.5876</pub-id><pub-id pub-id-type="pmcid">PMC5251169</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dhiman</surname><given-names>P</given-names></name><etal/></person-group><article-title>Methodological conduct of prognostic prediction models developed using machine learning in oncology: a systematic review</article-title><source>BMC Med. Res. Methodol.</source><year>2022</year><volume>22</volume><fpage>101</fpage><pub-id pub-id-type="doi">10.1186/s12874-022-01577-x</pub-id><pub-id pub-id-type="pmid">35395724</pub-id><pub-id pub-id-type="pmcid">PMC8991704</pub-id></element-citation><mixed-citation id="mc-CR10" publication-type="journal">Dhiman, P. et al. Methodological conduct of prognostic prediction models developed using machine learning in oncology: a systematic review. <italic toggle="yes">BMC Med. Res. Methodol.</italic><bold>22</bold>, 101 (2022).<pub-id pub-id-type="pmid">35395724</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12874-022-01577-x</pub-id><pub-id pub-id-type="pmcid">PMC8991704</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kelly</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Karthikesalingam</surname><given-names>A</given-names></name><name name-style="western"><surname>Suleyman</surname><given-names>M</given-names></name><name name-style="western"><surname>Corrado</surname><given-names>G</given-names></name><name name-style="western"><surname>King</surname><given-names>D</given-names></name></person-group><article-title>Key challenges for delivering clinical impact with artificial intelligence</article-title><source>BMC Med.</source><year>2019</year><volume>17</volume><fpage>195</fpage><pub-id pub-id-type="doi">10.1186/s12916-019-1426-2</pub-id><pub-id pub-id-type="pmid">31665002</pub-id><pub-id pub-id-type="pmcid">PMC6821018</pub-id></element-citation><mixed-citation id="mc-CR11" publication-type="journal">Kelly, C. J., Karthikesalingam, A., Suleyman, M., Corrado, G. &amp; King, D. Key challenges for delivering clinical impact with artificial intelligence. <italic toggle="yes">BMC Med.</italic><bold>17</bold>, 195 (2019).<pub-id pub-id-type="pmid">31665002</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12916-019-1426-2</pub-id><pub-id pub-id-type="pmcid">PMC6821018</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wynants</surname><given-names>L</given-names></name><etal/></person-group><article-title>Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal</article-title><source>BMJ</source><year>2020</year><volume>369</volume><fpage>m1328</fpage><pub-id pub-id-type="doi">10.1136/bmj.m1328</pub-id><pub-id pub-id-type="pmid">32265220</pub-id><pub-id pub-id-type="pmcid">PMC7222643</pub-id></element-citation><mixed-citation id="mc-CR12" publication-type="journal">Wynants, L. et al. Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal. <italic toggle="yes">BMJ</italic><bold>369</bold>, m1328 (2020).<pub-id pub-id-type="pmid">32265220</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmj.m1328</pub-id><pub-id pub-id-type="pmcid">PMC7222643</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>F</given-names></name><name name-style="western"><surname>Kaushal</surname><given-names>R</given-names></name><name name-style="western"><surname>Khullar</surname><given-names>D</given-names></name></person-group><article-title>Should Health Care Demand Interpretable Artificial Intelligence or Accept &#8220;Black Box&#8221; Medicine?</article-title><source>Ann. Intern Med.</source><year>2020</year><volume>172</volume><fpage>59</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.7326/M19-2548</pub-id><pub-id pub-id-type="pmid">31842204</pub-id></element-citation><mixed-citation id="mc-CR13" publication-type="journal">Wang, F., Kaushal, R. &amp; Khullar, D. Should Health Care Demand Interpretable Artificial Intelligence or Accept &#8220;Black Box&#8221; Medicine? <italic toggle="yes">Ann. Intern Med.</italic><bold>172</bold>, 59&#8211;60 (2020).<pub-id pub-id-type="pmid">31842204</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7326/M19-2548</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lipton</surname><given-names>Z</given-names></name></person-group><article-title>The mythos of model interpretability</article-title><source>Commun. ACM</source><year>2018</year><volume>61</volume><fpage>36</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1145/3233231</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Lipton, Z. The mythos of model interpretability. <italic toggle="yes">Commun. ACM</italic><bold>61</bold>, 36&#8211;43 (2018).</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ciobanu-Caraus</surname><given-names>O</given-names></name><etal/></person-group><article-title>A critical moment in machine learning in medicine: on reproducible and interpretable learning</article-title><source>Acta Neurochirurgica</source><year>2024</year><volume>166</volume><fpage>14</fpage><pub-id pub-id-type="doi">10.1007/s00701-024-05892-8</pub-id><pub-id pub-id-type="pmid">38227273</pub-id><pub-id pub-id-type="pmcid">PMC10791964</pub-id></element-citation><mixed-citation id="mc-CR15" publication-type="journal">Ciobanu-Caraus, O. et al. A critical moment in machine learning in medicine: on reproducible and interpretable learning. <italic toggle="yes">Acta Neurochirurgica</italic><bold>166</bold>, 14 (2024).<pub-id pub-id-type="pmid">38227273</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00701-024-05892-8</pub-id><pub-id pub-id-type="pmcid">PMC10791964</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Varoquaux</surname><given-names>G</given-names></name><name name-style="western"><surname>Cheplygina</surname><given-names>V</given-names></name></person-group><article-title>Machine learning for medical imaging: methodological failures and recommendations for the future</article-title><source>NPJ Digit Med.</source><year>2022</year><volume>5</volume><fpage>48</fpage><pub-id pub-id-type="doi">10.1038/s41746-022-00592-y</pub-id><pub-id pub-id-type="pmid">35413988</pub-id><pub-id pub-id-type="pmcid">PMC9005663</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">Varoquaux, G. &amp; Cheplygina, V. Machine learning for medical imaging: methodological failures and recommendations for the future. <italic toggle="yes">NPJ Digit Med.</italic><bold>5</bold>, 48 (2022).<pub-id pub-id-type="pmid">35413988</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41746-022-00592-y</pub-id><pub-id pub-id-type="pmcid">PMC9005663</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Christodoulou</surname><given-names>E</given-names></name><etal/></person-group><article-title>A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models</article-title><source>J. Clin. Epidemiol.</source><year>2019</year><volume>110</volume><fpage>12</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1016/j.jclinepi.2019.02.004</pub-id><pub-id pub-id-type="pmid">30763612</pub-id></element-citation><mixed-citation id="mc-CR17" publication-type="journal">Christodoulou, E. et al. A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models. <italic toggle="yes">J. Clin. Epidemiol.</italic><bold>110</bold>, 12&#8211;22 (2019).<pub-id pub-id-type="pmid">30763612</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jclinepi.2019.02.004</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sharma</surname><given-names>B</given-names></name><etal/></person-group><article-title>Publicly available machine learning models for identifying opioid misuse from the clinical notes of hospitalized patients</article-title><source>BMC Med. Inform. Decision Making</source><year>2020</year><volume>20</volume><fpage>79</fpage><pub-id pub-id-type="doi">10.1186/s12911-020-1099-y</pub-id><pub-id pub-id-type="pmcid">PMC7191715</pub-id><pub-id pub-id-type="pmid">32349766</pub-id></element-citation><mixed-citation id="mc-CR18" publication-type="journal">Sharma, B. et al. Publicly available machine learning models for identifying opioid misuse from the clinical notes of hospitalized patients. <italic toggle="yes">BMC Med. Inform. Decision Making</italic><bold>20</bold>, 79 (2020).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12911-020-1099-y</pub-id><pub-id pub-id-type="pmcid">PMC7191715</pub-id><pub-id pub-id-type="pmid">32349766</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sharma</surname><given-names>V</given-names></name><name name-style="western"><surname>Kulkarni</surname><given-names>V</given-names></name><name name-style="western"><surname>Eurich</surname><given-names>DT</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>L</given-names></name><name name-style="western"><surname>Samanani</surname><given-names>S</given-names></name></person-group><article-title>Safe opioid prescribing: a prognostic machine learning approach to predicting 30-day risk after an opioid dispensation in Alberta, Canada</article-title><source>BMJ open</source><year>2021</year><volume>11</volume><fpage>e043964</fpage><pub-id pub-id-type="doi">10.1136/bmjopen-2020-043964</pub-id><pub-id pub-id-type="pmid">34039572</pub-id><pub-id pub-id-type="pmcid">PMC8160164</pub-id></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Sharma, V., Kulkarni, V., Eurich, D. T., Kumar, L. &amp; Samanani, S. Safe opioid prescribing: a prognostic machine learning approach to predicting 30-day risk after an opioid dispensation in Alberta, Canada. <italic toggle="yes">BMJ open</italic><bold>11</bold>, e043964 (2021).<pub-id pub-id-type="pmid">34039572</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmjopen-2020-043964</pub-id><pub-id pub-id-type="pmcid">PMC8160164</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>YS</given-names></name><etal/></person-group><article-title>Individualized prospective prediction of opioid use disorder</article-title><source>Can. J. Psychiatry</source><year>2023</year><volume>68</volume><fpage>54</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1177/07067437221114094</pub-id><pub-id pub-id-type="pmid">35892186</pub-id><pub-id pub-id-type="pmcid">PMC9720482</pub-id></element-citation><mixed-citation id="mc-CR20" publication-type="journal">Liu, Y. S. et al. Individualized prospective prediction of opioid use disorder. <italic toggle="yes">Can. J. Psychiatry</italic><bold>68</bold>, 54&#8211;63 (2023).<pub-id pub-id-type="pmid">35892186</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/07067437221114094</pub-id><pub-id pub-id-type="pmcid">PMC9720482</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Behnoush</surname><given-names>B</given-names></name><etal/></person-group><article-title>Machine learning algorithms to predict seizure due to acute tramadol poisoning</article-title><source>Hum. Exp. Toxicol.</source><year>2021</year><volume>40</volume><fpage>1225</fpage><lpage>1233</lpage><pub-id pub-id-type="doi">10.1177/0960327121991910</pub-id><pub-id pub-id-type="pmid">33538187</pub-id></element-citation><mixed-citation id="mc-CR21" publication-type="journal">Behnoush, B. et al. Machine learning algorithms to predict seizure due to acute tramadol poisoning. <italic toggle="yes">Hum. Exp. Toxicol.</italic><bold>40</bold>, 1225&#8211;1233 (2021).<pub-id pub-id-type="pmid">33538187</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/0960327121991910</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Held</surname><given-names>U</given-names></name><etal/></person-group><article-title>Development and internal validation of a prediction model for long-term opioid use-an analysis of insurance claims data</article-title><source>Pain</source><year>2024</year><volume>165</volume><fpage>44</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">37782553</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/j.pain.0000000000003023</pub-id><pub-id pub-id-type="pmcid">PMC10723645</pub-id></element-citation><mixed-citation id="mc-CR22" publication-type="journal">Held, U. et al. Development and internal validation of a prediction model for long-term opioid use-an analysis of insurance claims data. <italic toggle="yes">Pain</italic><bold>165</bold>, 44&#8211;53 (2024).<pub-id pub-id-type="pmid">37782553</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/j.pain.0000000000003023</pub-id><pub-id pub-id-type="pmcid">PMC10723645</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Karhade</surname><given-names>AV</given-names></name><etal/></person-group><article-title>Predicting prolonged opioid prescriptions in opioid-na&#239;ve lumbar spine surgery patients</article-title><source>Spine J.</source><year>2020</year><volume>20</volume><fpage>888</fpage><lpage>895</lpage><pub-id pub-id-type="doi">10.1016/j.spinee.2019.12.019</pub-id><pub-id pub-id-type="pmid">31901553</pub-id></element-citation><mixed-citation id="mc-CR23" publication-type="journal">Karhade, A. V. et al. Predicting prolonged opioid prescriptions in opioid-na&#239;ve lumbar spine surgery patients. <italic toggle="yes">Spine J.</italic><bold>20</bold>, 888&#8211;895 (2020).<pub-id pub-id-type="pmid">31901553</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.spinee.2019.12.019</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Karhade</surname><given-names>AV</given-names></name><etal/></person-group><article-title>Development of machine learning algorithms for prediction of prolonged opioid prescription after surgery for lumbar disc herniation</article-title><source>Spine J.</source><year>2019</year><volume>19</volume><fpage>1764</fpage><lpage>1771</lpage><pub-id pub-id-type="doi">10.1016/j.spinee.2019.06.002</pub-id><pub-id pub-id-type="pmid">31185292</pub-id></element-citation><mixed-citation id="mc-CR24" publication-type="journal">Karhade, A. V. et al. Development of machine learning algorithms for prediction of prolonged opioid prescription after surgery for lumbar disc herniation. <italic toggle="yes">Spine J.</italic><bold>19</bold>, 1764&#8211;1771 (2019).<pub-id pub-id-type="pmid">31185292</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.spinee.2019.06.002</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Calcaterra</surname><given-names>SL</given-names></name><etal/></person-group><article-title>Prediction of Future Chronic Opioid Use Among Hospitalized Patients</article-title><source>J. Gen. Intern. Med.</source><year>2018</year><volume>33</volume><fpage>898</fpage><lpage>905</lpage><pub-id pub-id-type="doi">10.1007/s11606-018-4335-8</pub-id><pub-id pub-id-type="pmid">29404943</pub-id><pub-id pub-id-type="pmcid">PMC5975151</pub-id></element-citation><mixed-citation id="mc-CR25" publication-type="journal">Calcaterra, S. L. et al. Prediction of Future Chronic Opioid Use Among Hospitalized Patients. <italic toggle="yes">J. Gen. Intern. Med.</italic><bold>33</bold>, 898&#8211;905 (2018).<pub-id pub-id-type="pmid">29404943</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11606-018-4335-8</pub-id><pub-id pub-id-type="pmcid">PMC5975151</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lo-Ciganic</surname><given-names>W-H</given-names></name><etal/></person-group><article-title>Developing and validating a machine-learning algorithm to predict opioid overdose in Medicaid beneficiaries in two US states: a prognostic modelling study</article-title><source>Lancet Digi. Health</source><year>2022</year><volume>4</volume><fpage>e455</fpage><lpage>e465</lpage><pub-id pub-id-type="doi">10.1016/S2589-7500(22)00062-0</pub-id><pub-id pub-id-type="pmcid">PMC9236281</pub-id><pub-id pub-id-type="pmid">35623798</pub-id></element-citation><mixed-citation id="mc-CR26" publication-type="journal">Lo-Ciganic, W.-H. et al. Developing and validating a machine-learning algorithm to predict opioid overdose in Medicaid beneficiaries in two US states: a prognostic modelling study. <italic toggle="yes">Lancet Digi. Health</italic><bold>4</bold>, e455&#8211;e465 (2022).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S2589-7500(22)00062-0</pub-id><pub-id pub-id-type="pmcid">PMC9236281</pub-id><pub-id pub-id-type="pmid">35623798</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fouladvand</surname><given-names>S</given-names></name><etal/></person-group><article-title>A Comparative Effectiveness Study on Opioid Use Disorder Prediction Using Artificial Intelligence and Existing Risk Models</article-title><source>IEEE J. Biomed. Health Inform.</source><year>2023</year><volume>27</volume><fpage>3589</fpage><lpage>3598</lpage><pub-id pub-id-type="doi">10.1109/JBHI.2023.3265920</pub-id><pub-id pub-id-type="pmid">37037255</pub-id></element-citation><mixed-citation id="mc-CR27" publication-type="journal">Fouladvand, S. et al. A Comparative Effectiveness Study on Opioid Use Disorder Prediction Using Artificial Intelligence and Existing Risk Models. <italic toggle="yes">IEEE J. Biomed. Health Inform.</italic><bold>27</bold>, 3589&#8211;3598 (2023).<pub-id pub-id-type="pmid">37037255</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1109/JBHI.2023.3265920</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hur</surname><given-names>J</given-names></name><etal/></person-group><article-title>Predicting postoperative opioid use with machine learning and insurance claims in opioid-na&#239;ve patients</article-title><source>Am. J. Surg.</source><year>2021</year><volume>222</volume><fpage>659</fpage><lpage>665</lpage><pub-id pub-id-type="doi">10.1016/j.amjsurg.2021.03.058</pub-id><pub-id pub-id-type="pmid">33820654</pub-id><pub-id pub-id-type="pmcid">PMC8373633</pub-id></element-citation><mixed-citation id="mc-CR28" publication-type="journal">Hur, J. et al. Predicting postoperative opioid use with machine learning and insurance claims in opioid-na&#239;ve patients. <italic toggle="yes">Am. J. Surg.</italic><bold>222</bold>, 659&#8211;665 (2021).<pub-id pub-id-type="pmid">33820654</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.amjsurg.2021.03.058</pub-id><pub-id pub-id-type="pmcid">PMC8373633</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Segal</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Development of a machine learning algorithm for early detection of opioid use disorder</article-title><source>Pharmacol. Res. Perspect.</source><year>2020</year><volume>8</volume><fpage>e00669</fpage><pub-id pub-id-type="doi">10.1002/prp2.669</pub-id><pub-id pub-id-type="pmid">33200572</pub-id><pub-id pub-id-type="pmcid">PMC7670130</pub-id></element-citation><mixed-citation id="mc-CR29" publication-type="journal">Segal, Z. et al. Development of a machine learning algorithm for early detection of opioid use disorder. <italic toggle="yes">Pharmacol. Res. Perspect.</italic><bold>8</bold>, e00669 (2020).<pub-id pub-id-type="pmid">33200572</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/prp2.669</pub-id><pub-id pub-id-type="pmcid">PMC7670130</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Smeden</surname><given-names>M</given-names></name><name name-style="western"><surname>Reitsma</surname><given-names>JB</given-names></name><name name-style="western"><surname>Riley</surname><given-names>RD</given-names></name><name name-style="western"><surname>Collins</surname><given-names>GS</given-names></name><name name-style="western"><surname>Moons</surname><given-names>KG</given-names></name></person-group><article-title>Clinical prediction models: diagnosis versus prognosis</article-title><source>J. Clin. Epidemiol.</source><year>2021</year><volume>132</volume><fpage>142</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.1016/j.jclinepi.2021.01.009</pub-id><pub-id pub-id-type="pmid">33775387</pub-id></element-citation><mixed-citation id="mc-CR30" publication-type="journal">van Smeden, M., Reitsma, J. B., Riley, R. D., Collins, G. S. &amp; Moons, K. G. Clinical prediction models: diagnosis versus prognosis. <italic toggle="yes">J. Clin. Epidemiol.</italic><bold>132</bold>, 142&#8211;145 (2021).<pub-id pub-id-type="pmid">33775387</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jclinepi.2021.01.009</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Machine-learning model successfully predicts patients at risk for prolonged postoperative opioid use following elective knee arthroscopy</article-title><source>Knee Surg. Sports Traumatol. Arthrosc.</source><year>2022</year><volume>30</volume><fpage>762</fpage><lpage>772</lpage><pub-id pub-id-type="doi">10.1007/s00167-020-06421-7</pub-id><pub-id pub-id-type="pmid">33420807</pub-id></element-citation><mixed-citation id="mc-CR31" publication-type="journal">Lu, Y. et al. Machine-learning model successfully predicts patients at risk for prolonged postoperative opioid use following elective knee arthroscopy. <italic toggle="yes">Knee Surg. Sports Traumatol. Arthrosc.</italic><bold>30</bold>, 762&#8211;772 (2022).<pub-id pub-id-type="pmid">33420807</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00167-020-06421-7</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Katakam</surname><given-names>A</given-names></name><name name-style="western"><surname>Karhade</surname><given-names>AV</given-names></name><name name-style="western"><surname>Schwab</surname><given-names>JH</given-names></name><name name-style="western"><surname>Chen</surname><given-names>AF</given-names></name><name name-style="western"><surname>Bedair</surname><given-names>HS</given-names></name></person-group><article-title>Development and validation of machine learning algorithms for postoperative opioid prescriptions after TKA</article-title><source>J. Orthop.</source><year>2020</year><volume>22</volume><fpage>95</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1016/j.jor.2020.03.052</pub-id><pub-id pub-id-type="pmid">32300270</pub-id><pub-id pub-id-type="pmcid">PMC7152687</pub-id></element-citation><mixed-citation id="mc-CR32" publication-type="journal">Katakam, A., Karhade, A. V., Schwab, J. H., Chen, A. F. &amp; Bedair, H. S. Development and validation of machine learning algorithms for postoperative opioid prescriptions after TKA. <italic toggle="yes">J. Orthop.</italic><bold>22</bold>, 95&#8211;99 (2020).<pub-id pub-id-type="pmid">32300270</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jor.2020.03.052</pub-id><pub-id pub-id-type="pmcid">PMC7152687</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gabriel</surname><given-names>RA</given-names></name><etal/></person-group><article-title>Machine learning approach to predicting persistent opioid use following lower extremity joint arthroplasty</article-title><source>Reg. Anesthesia pain. Med.</source><year>2022</year><volume>47</volume><fpage>313</fpage><lpage>319</lpage><pub-id pub-id-type="doi">10.1136/rapm-2021-103299</pub-id><pub-id pub-id-type="pmcid">PMC8961772</pub-id><pub-id pub-id-type="pmid">35115414</pub-id></element-citation><mixed-citation id="mc-CR33" publication-type="journal">Gabriel, R. A. et al. Machine learning approach to predicting persistent opioid use following lower extremity joint arthroplasty. <italic toggle="yes">Reg. Anesthesia pain. Med.</italic><bold>47</bold>, 313&#8211;319 (2022).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/rapm-2021-103299</pub-id><pub-id pub-id-type="pmcid">PMC8961772</pub-id><pub-id pub-id-type="pmid">35115414</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Klemt</surname><given-names>C</given-names></name><etal/></person-group><article-title>Machine learning algorithms predict extended postoperative opioid use in primary total knee arthroplasty</article-title><source>Knee Surg., Sports Traumatol., Arthrosc.</source><year>2022</year><volume>30</volume><fpage>2573</fpage><lpage>2581</lpage><pub-id pub-id-type="doi">10.1007/s00167-021-06812-4</pub-id><pub-id pub-id-type="pmid">34984528</pub-id></element-citation><mixed-citation id="mc-CR34" publication-type="journal">Klemt, C. et al. Machine learning algorithms predict extended postoperative opioid use in primary total knee arthroplasty. <italic toggle="yes">Knee Surg., Sports Traumatol., Arthrosc.</italic><bold>30</bold>, 2573&#8211;2581 (2022).<pub-id pub-id-type="pmid">34984528</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00167-021-06812-4</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dong</surname><given-names>X</given-names></name><etal/></person-group><article-title>Predicting opioid overdose risk of patients with opioid prescriptions using electronic health records based on temporal deep learning</article-title><source>J. Biomed. Inform.</source><year>2021</year><volume>116</volume><fpage>103725</fpage><pub-id pub-id-type="doi">10.1016/j.jbi.2021.103725</pub-id><pub-id pub-id-type="pmid">33711546</pub-id></element-citation><mixed-citation id="mc-CR35" publication-type="journal">Dong, X. et al. Predicting opioid overdose risk of patients with opioid prescriptions using electronic health records based on temporal deep learning. <italic toggle="yes">J. Biomed. Inform.</italic><bold>116</bold>, 103725 (2021).<pub-id pub-id-type="pmid">33711546</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jbi.2021.103725</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dong</surname><given-names>X</given-names></name><etal/></person-group><article-title>Machine Learning Based Opioid Overdose Prediction Using Electronic Health Records</article-title><source>AMIA Annu. Symp. Proc.</source><year>2019</year><volume>2019</volume><fpage>389</fpage><lpage>398</lpage><pub-id pub-id-type="pmid">32308832</pub-id><pub-id pub-id-type="pmcid">PMC7153049</pub-id></element-citation><mixed-citation id="mc-CR36" publication-type="journal">Dong, X. et al. Machine Learning Based Opioid Overdose Prediction Using Electronic Health Records. <italic toggle="yes">AMIA Annu. Symp. Proc.</italic><bold>2019</bold>, 389&#8211;398 (2019).<pub-id pub-id-type="pmid">32308832</pub-id><pub-id pub-id-type="pmcid">PMC7153049</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gellad</surname><given-names>WF</given-names></name><etal/></person-group><article-title>Development and validation of an overdose risk prediction tool using prescription drug monitoring program data</article-title><source>Drug Alcohol Depend.</source><year>2023</year><volume>246</volume><fpage>109856</fpage><pub-id pub-id-type="doi">10.1016/j.drugalcdep.2023.109856</pub-id><pub-id pub-id-type="pmid">37001323</pub-id></element-citation><mixed-citation id="mc-CR37" publication-type="journal">Gellad, W. F. et al. Development and validation of an overdose risk prediction tool using prescription drug monitoring program data. <italic toggle="yes">Drug Alcohol Depend.</italic><bold>246</bold>, 109856 (2023).<pub-id pub-id-type="pmid">37001323</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.drugalcdep.2023.109856</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lo-Ciganic</surname><given-names>W-H</given-names></name><etal/></person-group><article-title>Integrating human services and criminal justice data with claims data to predict risk of opioid overdose among Medicaid beneficiaries: A machine-learning approach</article-title><source>PloS one</source><year>2021</year><volume>16</volume><fpage>e0248360</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0248360</pub-id><pub-id pub-id-type="pmid">33735222</pub-id><pub-id pub-id-type="pmcid">PMC7971495</pub-id></element-citation><mixed-citation id="mc-CR38" publication-type="journal">Lo-Ciganic, W.-H. et al. Integrating human services and criminal justice data with claims data to predict risk of opioid overdose among Medicaid beneficiaries: A machine-learning approach. <italic toggle="yes">PloS one</italic><bold>16</bold>, e0248360 (2021).<pub-id pub-id-type="pmid">33735222</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0248360</pub-id><pub-id pub-id-type="pmcid">PMC7971495</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lo-Ciganic</surname><given-names>W-H</given-names></name><etal/></person-group><article-title>Evaluation of Machine-Learning Algorithms for Predicting Opioid Overdose Risk Among Medicare Beneficiaries With Opioid Prescriptions</article-title><source>JAMA Netw. Open</source><year>2019</year><volume>2</volume><fpage>e190968</fpage><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2019.0968</pub-id><pub-id pub-id-type="pmid">30901048</pub-id><pub-id pub-id-type="pmcid">PMC6583312</pub-id></element-citation><mixed-citation id="mc-CR39" publication-type="journal">Lo-Ciganic, W.-H. et al. Evaluation of Machine-Learning Algorithms for Predicting Opioid Overdose Risk Among Medicare Beneficiaries With Opioid Prescriptions. <italic toggle="yes">JAMA Netw. Open</italic><bold>2</bold>, e190968 (2019).<pub-id pub-id-type="pmid">30901048</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamanetworkopen.2019.0968</pub-id><pub-id pub-id-type="pmcid">PMC6583312</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ripperger</surname><given-names>M</given-names></name><etal/></person-group><article-title>Ensemble learning to predict opioid-related overdose using statewide prescription drug monitoring program and hospital discharge data in the state of Tennessee</article-title><source>J. Am. Med. Inform. Assoc.: JAMIA</source><year>2021</year><volume>29</volume><fpage>22</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1093/jamia/ocab218</pub-id><pub-id pub-id-type="pmid">34665246</pub-id><pub-id pub-id-type="pmcid">PMC8714265</pub-id></element-citation><mixed-citation id="mc-CR40" publication-type="journal">Ripperger, M. et al. Ensemble learning to predict opioid-related overdose using statewide prescription drug monitoring program and hospital discharge data in the state of Tennessee. <italic toggle="yes">J. Am. Med. Inform. Assoc.: JAMIA</italic><bold>29</bold>, 22&#8211;32 (2021).<pub-id pub-id-type="pmid">34665246</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jamia/ocab218</pub-id><pub-id pub-id-type="pmcid">PMC8714265</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>JW</given-names></name><etal/></person-group><article-title>Predicting overdose among individuals prescribed opioids using routinely collected healthcare utilization data</article-title><source>PloS one</source><year>2020</year><volume>15</volume><fpage>e0241083</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0241083</pub-id><pub-id pub-id-type="pmid">33079968</pub-id><pub-id pub-id-type="pmcid">PMC7575098</pub-id></element-citation><mixed-citation id="mc-CR41" publication-type="journal">Sun, J. W. et al. Predicting overdose among individuals prescribed opioids using routinely collected healthcare utilization data. <italic toggle="yes">PloS one</italic><bold>15</bold>, e0241083 (2020).<pub-id pub-id-type="pmid">33079968</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0241083</pub-id><pub-id pub-id-type="pmcid">PMC7575098</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Annis</surname><given-names>IE</given-names></name><name name-style="western"><surname>Jordan</surname><given-names>R</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>KC</given-names></name></person-group><article-title>Quickly identifying people at risk of opioid use disorder in emergency departments: trade-offs between a machine learning approach and a simple EHR flag strategy</article-title><source>BMJ open</source><year>2022</year><volume>12</volume><fpage>e059414</fpage><pub-id pub-id-type="doi">10.1136/bmjopen-2021-059414</pub-id><pub-id pub-id-type="pmid">36104124</pub-id><pub-id pub-id-type="pmcid">PMC9476155</pub-id></element-citation><mixed-citation id="mc-CR42" publication-type="journal">Annis, I. E., Jordan, R. &amp; Thomas, K. C. Quickly identifying people at risk of opioid use disorder in emergency departments: trade-offs between a machine learning approach and a simple EHR flag strategy. <italic toggle="yes">BMJ open</italic><bold>12</bold>, e059414 (2022).<pub-id pub-id-type="pmid">36104124</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmjopen-2021-059414</pub-id><pub-id pub-id-type="pmcid">PMC9476155</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Banks</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>TD</given-names></name><name name-style="western"><surname>Uhlmann</surname><given-names>JK</given-names></name><name name-style="western"><surname>Nair</surname><given-names>SS</given-names></name><name name-style="western"><surname>Scherrer</surname><given-names>JF</given-names></name></person-group><article-title>Predicting opioid use disorder before and after the opioid prescribing peak in the United States: A machine learning tool using electronic healthcare records</article-title><source>Health Inform. J.</source><year>2023</year><volume>29</volume><fpage>14604582231168826</fpage><pub-id pub-id-type="doi">10.1177/14604582231168826</pub-id><pub-id pub-id-type="pmcid">PMC10158959</pub-id><pub-id pub-id-type="pmid">37042333</pub-id></element-citation><mixed-citation id="mc-CR43" publication-type="journal">Banks, T. J., Nguyen, T. D., Uhlmann, J. K., Nair, S. S. &amp; Scherrer, J. F. Predicting opioid use disorder before and after the opioid prescribing peak in the United States: A machine learning tool using electronic healthcare records. <italic toggle="yes">Health Inform. J.</italic><bold>29</bold>, 14604582231168826 (2023).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/14604582231168826</pub-id><pub-id pub-id-type="pmcid">PMC10158959</pub-id><pub-id pub-id-type="pmid">37042333</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dong</surname><given-names>X</given-names></name><etal/></person-group><article-title>Identifying risk of opioid use disorder for patients taking opioid medications with deep learning</article-title><source>J. Am. Med. Inform. Assoc. : JAMIA</source><year>2021</year><volume>28</volume><fpage>1683</fpage><lpage>1693</lpage><pub-id pub-id-type="doi">10.1093/jamia/ocab043</pub-id><pub-id pub-id-type="pmid">33930132</pub-id><pub-id pub-id-type="pmcid">PMC8324214</pub-id></element-citation><mixed-citation id="mc-CR44" publication-type="journal">Dong, X. et al. Identifying risk of opioid use disorder for patients taking opioid medications with deep learning. <italic toggle="yes">J. Am. Med. Inform. Assoc. : JAMIA</italic><bold>28</bold>, 1683&#8211;1693 (2021).<pub-id pub-id-type="pmid">33930132</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jamia/ocab043</pub-id><pub-id pub-id-type="pmcid">PMC8324214</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kunze</surname><given-names>KN</given-names></name><name name-style="western"><surname>Polce</surname><given-names>EM</given-names></name><name name-style="western"><surname>Alter</surname><given-names>TD</given-names></name><name name-style="western"><surname>Nho</surname><given-names>SJ</given-names></name></person-group><article-title>Machine Learning Algorithms Predict Prolonged Opioid Use in Opioid-Na&#239;ve Primary Hip Arthroscopy Patients</article-title><source>J. Am. Acad. Orthop. Surg. Glob. Res. Rev.</source><year>2021</year><volume>5</volume><fpage>00093</fpage><lpage>00098</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.5435/JAAOSGlobal-D-21-00093</pub-id><pub-id pub-id-type="pmcid">PMC8154386</pub-id><pub-id pub-id-type="pmid">34032690</pub-id></element-citation><mixed-citation id="mc-CR45" publication-type="journal">Kunze, K. N., Polce, E. M., Alter, T. D. &amp; Nho, S. J. Machine Learning Algorithms Predict Prolonged Opioid Use in Opioid-Na&#239;ve Primary Hip Arthroscopy Patients. <italic toggle="yes">J. Am. Acad. Orthop. Surg. Glob. Res. Rev.</italic><bold>5</bold>, 00093&#8211;00098 (2021).<pub-id pub-id-type="doi" assigning-authority="pmc">10.5435/JAAOSGlobal-D-21-00093</pub-id><pub-id pub-id-type="pmcid">PMC8154386</pub-id><pub-id pub-id-type="pmid">34032690</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grazal</surname><given-names>CF</given-names></name><etal/></person-group><article-title>A machine-learning algorithm to predict the likelihood of prolonged opioid use following arthroscopic hip surgery</article-title><source>Arthrosc.</source><year>2022</year><volume>38</volume><fpage>839</fpage><lpage>847.e832</lpage><pub-id pub-id-type="doi">10.1016/j.arthro.2021.08.009</pub-id><pub-id pub-id-type="pmid">34411683</pub-id></element-citation><mixed-citation id="mc-CR46" publication-type="journal">Grazal, C. F. et al. A machine-learning algorithm to predict the likelihood of prolonged opioid use following arthroscopic hip surgery. <italic toggle="yes">Arthrosc.</italic><bold>38</bold>, 839&#8211;847.e832 (2022).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.arthro.2021.08.009</pub-id><pub-id pub-id-type="pmid">34411683</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gao</surname><given-names>W</given-names></name><name name-style="western"><surname>Leighton</surname><given-names>C</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Jones</surname><given-names>J</given-names></name><name name-style="western"><surname>Mistry</surname><given-names>P</given-names></name></person-group><article-title>Predicting opioid use disorder and associated risk factors in a medicaid managed care population</article-title><source>Am. J. Managed Care</source><year>2021</year><volume>27</volume><fpage>148</fpage><lpage>154</lpage><pub-id pub-id-type="doi">10.37765/ajmc.2021.88617</pub-id><pub-id pub-id-type="pmid">33877773</pub-id></element-citation><mixed-citation id="mc-CR47" publication-type="journal">Gao, W., Leighton, C., Chen, Y., Jones, J. &amp; Mistry, P. Predicting opioid use disorder and associated risk factors in a medicaid managed care population. <italic toggle="yes">Am. J. Managed Care</italic><bold>27</bold>, 148&#8211;154 (2021).<pub-id pub-id-type="doi" assigning-authority="pmc">10.37765/ajmc.2021.88617</pub-id><pub-id pub-id-type="pmid">33877773</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kashyap</surname><given-names>A</given-names></name><name name-style="western"><surname>Callison-Burch</surname><given-names>C</given-names></name><name name-style="western"><surname>Boland</surname><given-names>MR</given-names></name></person-group><article-title>A deep learning method to detect opioid prescription and opioid use disorder from electronic health records</article-title><source>Int. J. Med. Inform.</source><year>2023</year><volume>171</volume><fpage>104979</fpage><pub-id pub-id-type="doi">10.1016/j.ijmedinf.2022.104979</pub-id><pub-id pub-id-type="pmid">36621078</pub-id><pub-id pub-id-type="pmcid">PMC9898169</pub-id></element-citation><mixed-citation id="mc-CR48" publication-type="journal">Kashyap, A., Callison-Burch, C. &amp; Boland, M. R. A deep learning method to detect opioid prescription and opioid use disorder from electronic health records. <italic toggle="yes">Int. J. Med. Inform.</italic><bold>171</bold>, 104979 (2023).<pub-id pub-id-type="pmid">36621078</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ijmedinf.2022.104979</pub-id><pub-id pub-id-type="pmcid">PMC9898169</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lo-Ciganic</surname><given-names>W-H</given-names></name><etal/></person-group><article-title>Using machine learning to predict risk of incident opioid use disorder among fee-for-service Medicare beneficiaries: A prognostic study</article-title><source>PloS one</source><year>2020</year><volume>15</volume><fpage>e0235981</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0235981</pub-id><pub-id pub-id-type="pmid">32678860</pub-id><pub-id pub-id-type="pmcid">PMC7367453</pub-id></element-citation><mixed-citation id="mc-CR49" publication-type="journal">Lo-Ciganic, W.-H. et al. Using machine learning to predict risk of incident opioid use disorder among fee-for-service Medicare beneficiaries: A prognostic study. <italic toggle="yes">PloS one</italic><bold>15</bold>, e0235981 (2020).<pub-id pub-id-type="pmid">32678860</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0235981</pub-id><pub-id pub-id-type="pmcid">PMC7367453</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bjarnadottir</surname><given-names>MV</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>DB</given-names></name><name name-style="western"><surname>Agarwal</surname><given-names>R</given-names></name><name name-style="western"><surname>Nelson</surname><given-names>DA</given-names></name></person-group><article-title>Aiding the prescriber: developing a machine learning approach to personalized risk modeling for chronic opioid therapy amongst US Army soldiers</article-title><source>Health Care Manag. Sci.</source><year>2022</year><volume>25</volume><fpage>649</fpage><lpage>665</lpage><pub-id pub-id-type="doi">10.1007/s10729-022-09605-4</pub-id><pub-id pub-id-type="pmid">35895214</pub-id></element-citation><mixed-citation id="mc-CR50" publication-type="journal">Bjarnadottir, M. V., Anderson, D. B., Agarwal, R. &amp; Nelson, D. A. Aiding the prescriber: developing a machine learning approach to personalized risk modeling for chronic opioid therapy amongst US Army soldiers. <italic toggle="yes">Health Care Manag. Sci.</italic><bold>25</bold>, 649&#8211;665 (2022).<pub-id pub-id-type="pmid">35895214</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10729-022-09605-4</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR51"><label>51.</label><mixed-citation publication-type="other">Johnson, D. G. et al. Prescription quantity and duration predict progression from acute to chronic opioid use in opioid-naive Medicaid patients. <italic toggle="yes">PLOS Digit. Health</italic><bold>1</bold>, 10.1371/journal.pdig.0000075 (2022).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pdig.0000075</pub-id><pub-id pub-id-type="pmcid">PMC9534483</pub-id><pub-id pub-id-type="pmid">36203857</pub-id></mixed-citation></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mohl</surname><given-names>JT</given-names></name><etal/></person-group><article-title>Predicting Chronic Opioid Use Among Patients With Osteoarthritis Using Electronic Health Record Data</article-title><source>Arthritis Care Res.</source><year>2023</year><volume>75</volume><fpage>1511</fpage><lpage>1518</lpage><pub-id pub-id-type="doi">10.1002/acr.25013</pub-id><pub-id pub-id-type="pmid">36063399</pub-id></element-citation><mixed-citation id="mc-CR52" publication-type="journal">Mohl, J. T. et al. Predicting Chronic Opioid Use Among Patients With Osteoarthritis Using Electronic Health Record Data. <italic toggle="yes">Arthritis Care Res.</italic><bold>75</bold>, 1511&#8211;1518 (2023).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/acr.25013</pub-id><pub-id pub-id-type="pmid">36063399</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sharma</surname><given-names>V</given-names></name><etal/></person-group><article-title>Development and Validation of a Machine Learning Model to Estimate Risk of Adverse Outcomes Within 30 Days of Opioid Dispensation</article-title><source>JAMA Netw. Open</source><year>2022</year><volume>5</volume><fpage>e2248559</fpage><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2022.48559</pub-id><pub-id pub-id-type="pmid">36574245</pub-id><pub-id pub-id-type="pmcid">PMC9857580</pub-id></element-citation><mixed-citation id="mc-CR53" publication-type="journal">Sharma, V. et al. Development and Validation of a Machine Learning Model to Estimate Risk of Adverse Outcomes Within 30 Days of Opioid Dispensation. <italic toggle="yes">JAMA Netw. Open</italic><bold>5</bold>, e2248559 (2022).<pub-id pub-id-type="pmid">36574245</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamanetworkopen.2022.48559</pub-id><pub-id pub-id-type="pmcid">PMC9857580</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vunikili</surname><given-names>R</given-names></name><etal/></person-group><article-title>Predictive modelling of susceptibility to substance abuse, mortality and drug-drug interactions in opioid patients</article-title><source>Front. Artif. Intell.</source><year>2021</year><volume>4</volume><fpage>742723</fpage><pub-id pub-id-type="doi">10.3389/frai.2021.742723</pub-id><pub-id pub-id-type="pmid">34957391</pub-id><pub-id pub-id-type="pmcid">PMC8702828</pub-id></element-citation><mixed-citation id="mc-CR54" publication-type="journal">Vunikili, R. et al. Predictive modelling of susceptibility to substance abuse, mortality and drug-drug interactions in opioid patients. <italic toggle="yes">Front. Artif. Intell.</italic><bold>4</bold>, 742723 (2021).<pub-id pub-id-type="pmid">34957391</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/frai.2021.742723</pub-id><pub-id pub-id-type="pmcid">PMC8702828</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR55"><label>55.</label><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Che</surname><given-names>Z</given-names></name><name name-style="western"><surname>St Sauver</surname><given-names>J</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name></person-group><article-title>Deep Learning Solutions for Classifying Patients on Opioid Use</article-title><source>AMIA &#8230; Annu. Symp. Proc. AMIA Symp.</source><year>2017</year><volume>2017</volume><fpage>525</fpage><lpage>534</lpage><pub-id pub-id-type="pmid">29854117</pub-id><pub-id pub-id-type="pmcid">PMC5977635</pub-id></element-citation><mixed-citation id="mc-CR55" publication-type="journal">Che, Z., St Sauver, J., Liu, H. &amp; Liu, Y. Deep Learning Solutions for Classifying Patients on Opioid Use. <italic toggle="yes">AMIA &#8230; Annu. Symp. Proc. AMIA Symp.</italic><bold>2017</bold>, 525&#8211;534 (2017).<pub-id pub-id-type="pmid">29854117</pub-id><pub-id pub-id-type="pmcid">PMC5977635</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR56"><label>56.</label><citation-alternatives><element-citation id="ec-CR56" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ellis</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Genes</surname><given-names>N</given-names></name><name name-style="western"><surname>Ma&#8217;ayan</surname><given-names>A</given-names></name></person-group><article-title>Predicting opioid dependence from electronic health records with machine learning</article-title><source>BioData Min.</source><year>2019</year><volume>12</volume><fpage>3</fpage><pub-id pub-id-type="doi">10.1186/s13040-019-0193-0</pub-id><pub-id pub-id-type="pmid">30728857</pub-id><pub-id pub-id-type="pmcid">PMC6352440</pub-id></element-citation><mixed-citation id="mc-CR56" publication-type="journal">Ellis, R. J., Wang, Z., Genes, N. &amp; Ma&#8217;ayan, A. Predicting opioid dependence from electronic health records with machine learning. <italic toggle="yes">BioData Min.</italic><bold>12</bold>, 3 (2019).<pub-id pub-id-type="pmid">30728857</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13040-019-0193-0</pub-id><pub-id pub-id-type="pmcid">PMC6352440</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR57"><label>57.</label><citation-alternatives><element-citation id="ec-CR57" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>J</given-names></name><etal/></person-group><article-title>Predicting Mortality Risk After a Hospital or Emergency Department Visit for Nonfatal Opioid Overdose</article-title><source>J. Gen. Intern. Med.</source><year>2021</year><volume>36</volume><fpage>908</fpage><lpage>915</lpage><pub-id pub-id-type="doi">10.1007/s11606-020-06405-w</pub-id><pub-id pub-id-type="pmid">33481168</pub-id><pub-id pub-id-type="pmcid">PMC8041978</pub-id></element-citation><mixed-citation id="mc-CR57" publication-type="journal">Guo, J. et al. Predicting Mortality Risk After a Hospital or Emergency Department Visit for Nonfatal Opioid Overdose. <italic toggle="yes">J. Gen. Intern. Med.</italic><bold>36</bold>, 908&#8211;915 (2021).<pub-id pub-id-type="pmid">33481168</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11606-020-06405-w</pub-id><pub-id pub-id-type="pmcid">PMC8041978</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR58"><label>58.</label><citation-alternatives><element-citation id="ec-CR58" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anderson</surname><given-names>AB</given-names></name><etal/></person-group><article-title>Can Predictive Modeling Tools Identify Patients at High Risk of Prolonged Opioid Use after ACL Reconstruction?</article-title><source>Clin. Orthop. Relat. Res.</source><year>2020</year><volume>478</volume><fpage>00</fpage><lpage>1618</lpage><pub-id pub-id-type="doi">10.1097/CORR.0000000000001251</pub-id><pub-id pub-id-type="pmcid">PMC7310396</pub-id><pub-id pub-id-type="pmid">32282466</pub-id></element-citation><mixed-citation id="mc-CR58" publication-type="journal">Anderson, A. B. et al. Can Predictive Modeling Tools Identify Patients at High Risk of Prolonged Opioid Use after ACL Reconstruction? <italic toggle="yes">Clin. Orthop. Relat. Res.</italic><bold>478</bold>, 00&#8211;1618 (2020).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/CORR.0000000000001251</pub-id><pub-id pub-id-type="pmcid">PMC7310396</pub-id><pub-id pub-id-type="pmid">32282466</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR59"><label>59.</label><citation-alternatives><element-citation id="ec-CR59" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Karhade</surname><given-names>AV</given-names></name><name name-style="western"><surname>Schwab</surname><given-names>JH</given-names></name><name name-style="western"><surname>Bedair</surname><given-names>HS</given-names></name></person-group><article-title>Development of Machine Learning Algorithms for Prediction of Sustained Postoperative Opioid Prescriptions After Total Hip Arthroplasty</article-title><source>J. Arthroplast.</source><year>2019</year><volume>34</volume><fpage>2272</fpage><lpage>2277.e2271</lpage><pub-id pub-id-type="doi">10.1016/j.arth.2019.06.013</pub-id><pub-id pub-id-type="pmid">31327647</pub-id></element-citation><mixed-citation id="mc-CR59" publication-type="journal">Karhade, A. V., Schwab, J. H. &amp; Bedair, H. S. Development of Machine Learning Algorithms for Prediction of Sustained Postoperative Opioid Prescriptions After Total Hip Arthroplasty. <italic toggle="yes">J. Arthroplast.</italic><bold>34</bold>, 2272&#8211;2277.e2271 (2019).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.arth.2019.06.013</pub-id><pub-id pub-id-type="pmid">31327647</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR60"><label>60.</label><citation-alternatives><element-citation id="ec-CR60" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Karhade</surname><given-names>AV</given-names></name><etal/></person-group><article-title>Machine learning for prediction of sustained opioid prescription after anterior cervical discectomy and fusion</article-title><source>Spine J.</source><year>2019</year><volume>19</volume><fpage>976</fpage><lpage>983</lpage><pub-id pub-id-type="doi">10.1016/j.spinee.2019.01.009</pub-id><pub-id pub-id-type="pmid">30710731</pub-id></element-citation><mixed-citation id="mc-CR60" publication-type="journal">Karhade, A. V. et al. Machine learning for prediction of sustained opioid prescription after anterior cervical discectomy and fusion. <italic toggle="yes">Spine J.</italic><bold>19</bold>, 976&#8211;983 (2019).<pub-id pub-id-type="pmid">30710731</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.spinee.2019.01.009</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR61"><label>61.</label><citation-alternatives><element-citation id="ec-CR61" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>A predictive-modeling based screening tool for prolonged opioid use after surgical management of low back and lower extremity pain</article-title><source>Spine J.</source><year>2020</year><volume>20</volume><fpage>1184</fpage><lpage>1195</lpage><pub-id pub-id-type="doi">10.1016/j.spinee.2020.05.098</pub-id><pub-id pub-id-type="pmid">32445803</pub-id></element-citation><mixed-citation id="mc-CR61" publication-type="journal">Zhang, Y. et al. A predictive-modeling based screening tool for prolonged opioid use after surgical management of low back and lower extremity pain. <italic toggle="yes">Spine J.</italic><bold>20</bold>, 1184&#8211;1195 (2020).<pub-id pub-id-type="pmid">32445803</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.spinee.2020.05.098</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR62"><label>62.</label><citation-alternatives><element-citation id="ec-CR62" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Giladi</surname><given-names>AM</given-names></name><etal/></person-group><article-title>Patient-Reported Data Augment Prediction Models of Persistent Opioid Use after Elective Upper Extremity Surgery</article-title><source>Plast. Reconstruct. Surg.</source><year>2023</year><volume>152</volume><fpage>358e</fpage><lpage>366e</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/PRS.0000000000010297</pub-id><pub-id pub-id-type="pmcid">PMC11835507</pub-id><pub-id pub-id-type="pmid">36780362</pub-id></element-citation><mixed-citation id="mc-CR62" publication-type="journal">Giladi, A. M. et al. Patient-Reported Data Augment Prediction Models of Persistent Opioid Use after Elective Upper Extremity Surgery. <italic toggle="yes">Plast. Reconstruct. Surg.</italic><bold>152</bold>, 358e&#8211;366e (2023).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/PRS.0000000000010297</pub-id><pub-id pub-id-type="pmcid">PMC11835507</pub-id><pub-id pub-id-type="pmid">36780362</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR63"><label>63.</label><citation-alternatives><element-citation id="ec-CR63" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baxter</surname><given-names>NB</given-names></name><etal/></person-group><article-title>Predicting persistent opioid use after hand surgery: a machine learning approach</article-title><source>Plast. Reconstr. Surg.</source><year>2024</year><volume>54</volume><fpage>573</fpage><lpage>580</lpage><pub-id pub-id-type="doi">10.1097/PRS.0000000000011099</pub-id><pub-id pub-id-type="pmid">37772891</pub-id></element-citation><mixed-citation id="mc-CR63" publication-type="journal">Baxter, N. B. et al. Predicting persistent opioid use after hand surgery: a machine learning approach. <italic toggle="yes">Plast. Reconstr. Surg.</italic><bold>54</bold>, 573&#8211;580 (2024).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/PRS.0000000000011099</pub-id><pub-id pub-id-type="pmid">37772891</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR64"><label>64.</label><citation-alternatives><element-citation id="ec-CR64" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>Y-T</given-names></name><name name-style="western"><surname>Jenkins</surname><given-names>DA</given-names></name><name name-style="western"><surname>Peek</surname><given-names>N</given-names></name><name name-style="western"><surname>Dixon</surname><given-names>WG</given-names></name><name name-style="western"><surname>Jani</surname><given-names>M</given-names></name></person-group><article-title>High frequency of long-term opioid use among patients with rheumatic and musculoskeletal diseases initiating opioids for the first time</article-title><source>Ann. Rheumatic Dis.</source><year>2023</year><volume>82</volume><fpage>1116</fpage><lpage>1117</lpage><pub-id pub-id-type="doi">10.1136/ard-2023-224118</pub-id><pub-id pub-id-type="pmid">37193609</pub-id></element-citation><mixed-citation id="mc-CR64" publication-type="journal">Huang, Y.-T., Jenkins, D. A., Peek, N., Dixon, W. G. &amp; Jani, M. High frequency of long-term opioid use among patients with rheumatic and musculoskeletal diseases initiating opioids for the first time. <italic toggle="yes">Ann. Rheumatic Dis.</italic><bold>82</bold>, 1116&#8211;1117 (2023).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/ard-2023-224118</pub-id><pub-id pub-id-type="pmid">37193609</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR65"><label>65.</label><mixed-citation publication-type="other">Chen, S.-F. et al. External validation of machine learning algorithm predicting prolonged opioid prescriptions in opioid-naive lumbar spine surgery patients using a Taiwanese cohort. <italic toggle="yes">J. Formosan Med. Associat</italic>. 10.1016/j.jfma.2023.06.027 (2023).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jfma.2023.06.027</pub-id><pub-id pub-id-type="pmid">37453900</pub-id></mixed-citation></ref><ref id="CR66"><label>66.</label><citation-alternatives><element-citation id="ec-CR66" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yen</surname><given-names>H-K</given-names></name><etal/></person-group><article-title>A machine learning algorithm for predicting prolonged postoperative opioid prescription after lumbar disc herniation surgery. An external validation study using 1,316 patients from a Taiwanese cohort</article-title><source>Spine J.</source><year>2022</year><volume>22</volume><fpage>1119</fpage><lpage>1130</lpage><pub-id pub-id-type="doi">10.1016/j.spinee.2022.02.009</pub-id><pub-id pub-id-type="pmid">35202784</pub-id></element-citation><mixed-citation id="mc-CR66" publication-type="journal">Yen, H.-K. et al. A machine learning algorithm for predicting prolonged postoperative opioid prescription after lumbar disc herniation surgery. An external validation study using 1,316 patients from a Taiwanese cohort. <italic toggle="yes">Spine J.</italic><bold>22</bold>, 1119&#8211;1130 (2022).<pub-id pub-id-type="pmid">35202784</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.spinee.2022.02.009</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR67"><label>67.</label><citation-alternatives><element-citation id="ec-CR67" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nahm</surname><given-names>FS</given-names></name></person-group><article-title>Receiver operating characteristic curve: overview and practical use for clinicians</article-title><source>Korean J. Anesthesiol.</source><year>2022</year><volume>75</volume><fpage>25</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.4097/kja.21209</pub-id><pub-id pub-id-type="pmid">35124947</pub-id><pub-id pub-id-type="pmcid">PMC8831439</pub-id></element-citation><mixed-citation id="mc-CR67" publication-type="journal">Nahm, F. S. Receiver operating characteristic curve: overview and practical use for clinicians. <italic toggle="yes">Korean J. Anesthesiol.</italic><bold>75</bold>, 25&#8211;36 (2022).<pub-id pub-id-type="pmid">35124947</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4097/kja.21209</pub-id><pub-id pub-id-type="pmcid">PMC8831439</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR68"><label>68.</label><mixed-citation publication-type="other">Monaghan, T. F. et al. Foundational statistical principles in medical research: sensitivity, specificity, positive predictive value, and negative predictive value. <italic toggle="yes">Medicina (Kaunas)</italic><bold>57</bold>, 10.3390/medicina57050503 (2021).<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/medicina57050503</pub-id><pub-id pub-id-type="pmcid">PMC8156826</pub-id><pub-id pub-id-type="pmid">34065637</pub-id></mixed-citation></ref><ref id="CR69"><label>69.</label><citation-alternatives><element-citation id="ec-CR69" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Movahedi</surname><given-names>F</given-names></name><name name-style="western"><surname>Padman</surname><given-names>R</given-names></name><name name-style="western"><surname>Antaki</surname><given-names>JF</given-names></name></person-group><article-title>Limitations of receiver operating characteristic curve on imbalanced data: Assist device mortality risk scores</article-title><source>J. Thorac. Cardiovasc Surg.</source><year>2023</year><volume>165</volume><fpage>1433</fpage><lpage>1442.e1432</lpage><pub-id pub-id-type="doi">10.1016/j.jtcvs.2021.07.041</pub-id><pub-id pub-id-type="pmid">34446286</pub-id><pub-id pub-id-type="pmcid">PMC8800945</pub-id></element-citation><mixed-citation id="mc-CR69" publication-type="journal">Movahedi, F., Padman, R. &amp; Antaki, J. F. Limitations of receiver operating characteristic curve on imbalanced data: Assist device mortality risk scores. <italic toggle="yes">J. Thorac. Cardiovasc Surg.</italic><bold>165</bold>, 1433&#8211;1442.e1432 (2023).<pub-id pub-id-type="pmid">34446286</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jtcvs.2021.07.041</pub-id><pub-id pub-id-type="pmcid">PMC8800945</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR70"><label>70.</label><citation-alternatives><element-citation id="ec-CR70" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shin</surname><given-names>J</given-names></name></person-group><article-title>Feasibility of local interpretable model-agnostic explanations (LIME) algorithm as an effective and interpretable feature selection method: comparative fNIRS study</article-title><source>Biomed. Eng. Lett.</source><year>2023</year><volume>13</volume><fpage>689</fpage><lpage>703</lpage><pub-id pub-id-type="doi">10.1007/s13534-023-00291-x</pub-id><pub-id pub-id-type="pmid">37873000</pub-id><pub-id pub-id-type="pmcid">PMC10590353</pub-id></element-citation><mixed-citation id="mc-CR70" publication-type="journal">Shin, J. Feasibility of local interpretable model-agnostic explanations (LIME) algorithm as an effective and interpretable feature selection method: comparative fNIRS study. <italic toggle="yes">Biomed. Eng. Lett.</italic><bold>13</bold>, 689&#8211;703 (2023).<pub-id pub-id-type="pmid">37873000</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s13534-023-00291-x</pub-id><pub-id pub-id-type="pmcid">PMC10590353</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR71"><label>71.</label><citation-alternatives><element-citation id="ec-CR71" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rodr&#237;guez-P&#233;rez</surname><given-names>R</given-names></name><name name-style="western"><surname>Bajorath</surname><given-names>J</given-names></name></person-group><article-title>Interpretation of machine learning models using shapley values: application to compound potency and multi-target activity predictions</article-title><source>J. Comput Aided Mol. Des.</source><year>2020</year><volume>34</volume><fpage>1013</fpage><lpage>1026</lpage><pub-id pub-id-type="doi">10.1007/s10822-020-00314-0</pub-id><pub-id pub-id-type="pmid">32361862</pub-id><pub-id pub-id-type="pmcid">PMC7449951</pub-id></element-citation><mixed-citation id="mc-CR71" publication-type="journal">Rodr&#237;guez-P&#233;rez, R. &amp; Bajorath, J. Interpretation of machine learning models using shapley values: application to compound potency and multi-target activity predictions. <italic toggle="yes">J. Comput Aided Mol. Des.</italic><bold>34</bold>, 1013&#8211;1026 (2020).<pub-id pub-id-type="pmid">32361862</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10822-020-00314-0</pub-id><pub-id pub-id-type="pmcid">PMC7449951</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR72"><label>72.</label><mixed-citation publication-type="other">Durgia, C. <italic toggle="yes">Using SHAP for Explainability &#8212; Understand these Limitations First</italic>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://towardsdatascience.com/using-shap-for-explainability-understand-these-limitations-first-1bed91c9d21">https://towardsdatascience.com/using-shap-for-explainability-understand-these-limitations-first-1bed91c9d21</ext-link> (2021).</mixed-citation></ref><ref id="CR73"><label>73.</label><citation-alternatives><element-citation id="ec-CR73" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>X</given-names></name><name name-style="western"><surname>Marques-Silva</surname><given-names>J</given-names></name></person-group><article-title>On the failings of Shapley values for explainability</article-title><source>Int. J. Approx. Reason.</source><year>2024</year><volume>171</volume><fpage>109112</fpage><pub-id pub-id-type="doi">10.1016/j.ijar.2023.109112</pub-id></element-citation><mixed-citation id="mc-CR73" publication-type="journal">Huang, X. &amp; Marques-Silva, J. On the failings of Shapley values for explainability. <italic toggle="yes">Int. J. Approx. Reason.</italic><bold>171</bold>, 109112 (2024).</mixed-citation></citation-alternatives></ref><ref id="CR74"><label>74.</label><citation-alternatives><element-citation id="ec-CR74" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Obermeyer</surname><given-names>Z</given-names></name><name name-style="western"><surname>Powers</surname><given-names>B</given-names></name><name name-style="western"><surname>Vogeli</surname><given-names>C</given-names></name><name name-style="western"><surname>Mullainathan</surname><given-names>S</given-names></name></person-group><article-title>Dissecting racial bias in an algorithm used to manage the health of populations</article-title><source>Science</source><year>2019</year><volume>366</volume><fpage>447</fpage><lpage>453</lpage><pub-id pub-id-type="doi">10.1126/science.aax2342</pub-id><pub-id pub-id-type="pmid">31649194</pub-id></element-citation><mixed-citation id="mc-CR74" publication-type="journal">Obermeyer, Z., Powers, B., Vogeli, C. &amp; Mullainathan, S. Dissecting racial bias in an algorithm used to manage the health of populations. <italic toggle="yes">Science</italic><bold>366</bold>, 447&#8211;453 (2019).<pub-id pub-id-type="pmid">31649194</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.aax2342</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR75"><label>75.</label><citation-alternatives><element-citation id="ec-CR75" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goesling</surname><given-names>J</given-names></name><etal/></person-group><article-title>Trends and predictors of opioid use after total knee and total hip arthroplasty</article-title><source>Pain</source><year>2016</year><volume>157</volume><fpage>1259</fpage><lpage>1265</lpage><pub-id pub-id-type="doi">10.1097/j.pain.0000000000000516</pub-id><pub-id pub-id-type="pmid">26871536</pub-id><pub-id pub-id-type="pmcid">PMC4868627</pub-id></element-citation><mixed-citation id="mc-CR75" publication-type="journal">Goesling, J. et al. Trends and predictors of opioid use after total knee and total hip arthroplasty. <italic toggle="yes">Pain</italic><bold>157</bold>, 1259&#8211;1265 (2016).<pub-id pub-id-type="pmid">26871536</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/j.pain.0000000000000516</pub-id><pub-id pub-id-type="pmcid">PMC4868627</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR76"><label>76.</label><citation-alternatives><element-citation id="ec-CR76" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jani</surname><given-names>M</given-names></name><etal/></person-group><article-title>Take up to eight tablets per day&#8221;: Incorporating free-text medication instructions into a transparent and reproducible process for preparing drug exposure data for pharmacoepidemiology</article-title><source>Pharmacoepidemiol Drug Saf.</source><year>2023</year><volume>32</volume><fpage>651</fpage><lpage>660</lpage><pub-id pub-id-type="doi">10.1002/pds.5595</pub-id><pub-id pub-id-type="pmid">36718594</pub-id><pub-id pub-id-type="pmcid">PMC10947089</pub-id></element-citation><mixed-citation id="mc-CR76" publication-type="journal">Jani, M. et al. Take up to eight tablets per day&#8221;: Incorporating free-text medication instructions into a transparent and reproducible process for preparing drug exposure data for pharmacoepidemiology. <italic toggle="yes">Pharmacoepidemiol Drug Saf.</italic><bold>32</bold>, 651&#8211;660 (2023).<pub-id pub-id-type="pmid">36718594</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/pds.5595</pub-id><pub-id pub-id-type="pmcid">PMC10947089</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR77"><label>77.</label><mixed-citation publication-type="other">Savcisens, G. et al. Using sequences of life-events to predict human lives. <italic toggle="yes">Nat. Comput. Sci.</italic> 1&#8211;14 (2023).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s43588-023-00573-5</pub-id><pub-id pub-id-type="pmid">38177491</pub-id></mixed-citation></ref><ref id="CR78"><label>78.</label><citation-alternatives><element-citation id="ec-CR78" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Denecke</surname><given-names>K</given-names></name><name name-style="western"><surname>May</surname><given-names>R</given-names></name><name name-style="western"><surname>Rivera-Romero</surname><given-names>O</given-names></name></person-group><article-title>Transformer Models in Healthcare: A Survey and Thematic Analysis of Potentials, Shortcomings and Risks</article-title><source>J. Med Syst.</source><year>2024</year><volume>48</volume><fpage>23</fpage><pub-id pub-id-type="doi">10.1007/s10916-024-02043-5</pub-id><pub-id pub-id-type="pmid">38367119</pub-id><pub-id pub-id-type="pmcid">PMC10874304</pub-id></element-citation><mixed-citation id="mc-CR78" publication-type="journal">Denecke, K., May, R. &amp; Rivera-Romero, O. Transformer Models in Healthcare: A Survey and Thematic Analysis of Potentials, Shortcomings and Risks. <italic toggle="yes">J. Med Syst.</italic><bold>48</bold>, 23 (2024).<pub-id pub-id-type="pmid">38367119</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10916-024-02043-5</pub-id><pub-id pub-id-type="pmcid">PMC10874304</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR79"><label>79.</label><citation-alternatives><element-citation id="ec-CR79" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Garbin</surname><given-names>C</given-names></name><name name-style="western"><surname>Marques</surname><given-names>N</given-names></name><name name-style="western"><surname>Marques</surname><given-names>O</given-names></name></person-group><article-title>Machine learning for predicting opioid use disorder from healthcare data: A systematic review</article-title><source>Comput. methods Prog. Biomed.</source><year>2023</year><volume>236</volume><fpage>107573</fpage><pub-id pub-id-type="doi">10.1016/j.cmpb.2023.107573</pub-id><pub-id pub-id-type="pmid">37148670</pub-id></element-citation><mixed-citation id="mc-CR79" publication-type="journal">Garbin, C., Marques, N. &amp; Marques, O. Machine learning for predicting opioid use disorder from healthcare data: A systematic review. <italic toggle="yes">Comput. methods Prog. Biomed.</italic><bold>236</bold>, 107573 (2023).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cmpb.2023.107573</pub-id><pub-id pub-id-type="pmid">37148670</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR80"><label>80.</label><citation-alternatives><element-citation id="ec-CR80" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Emam</surname><given-names>OS</given-names></name><etal/></person-group><article-title>Machine learning algorithms predict long-term postoperative opioid misuse: a systematic review</article-title><source>Am Surg.</source><year>2024</year><volume>90</volume><fpage>140</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1177/00031348231198112</pub-id><pub-id pub-id-type="pmid">37732536</pub-id></element-citation><mixed-citation id="mc-CR80" publication-type="journal">Emam, O. S. et al. Machine learning algorithms predict long-term postoperative opioid misuse: a systematic review. <italic toggle="yes">Am Surg.</italic><bold>90</bold>, 140&#8211;151 (2024).<pub-id pub-id-type="pmid">37732536</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/00031348231198112</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR81"><label>81.</label><citation-alternatives><element-citation id="ec-CR81" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Page</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>The PRISMA 2020 statement: an updated guideline for reporting systematic reviews</article-title><source>BMJ</source><year>2021</year><volume>372</volume><fpage>n71</fpage><pub-id pub-id-type="doi">10.1136/bmj.n71</pub-id><pub-id pub-id-type="pmid">33782057</pub-id><pub-id pub-id-type="pmcid">PMC8005924</pub-id></element-citation><mixed-citation id="mc-CR81" publication-type="journal">Page, M. J. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. <italic toggle="yes">BMJ</italic><bold>372</bold>, n71 (2021).<pub-id pub-id-type="pmid">33782057</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmj.n71</pub-id><pub-id pub-id-type="pmcid">PMC8005924</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR82"><label>82.</label><mixed-citation publication-type="other">Taylor S. et al. Dependence and withdrawal associated with some prescribed medicines: An evidence review. <italic toggle="yes">Public Health England</italic> (2019) <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://assets.publishing.service.gov.uk/media/5fc658398fa8f5474c800149/PHE_PMR_report_Dec2020.pdf">https://assets.publishing.service.gov.uk/media/5fc658398fa8f5474c800149/PHE_PMR_report_Dec2020.pdf</ext-link>.</mixed-citation></ref><ref id="CR83"><label>83.</label><citation-alternatives><element-citation id="ec-CR83" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Andaur Navarro</surname><given-names>CL</given-names></name><etal/></person-group><article-title>Systematic review finds &#8220;spin&#8221; practices and poor reporting standards in studies on machine learning-based prediction models</article-title><source>J. Clin. Epidemiol.</source><year>2023</year><volume>158</volume><fpage>99</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1016/j.jclinepi.2023.03.024</pub-id><pub-id pub-id-type="pmid">37024020</pub-id></element-citation><mixed-citation id="mc-CR83" publication-type="journal">Andaur Navarro, C. L. et al. Systematic review finds &#8220;spin&#8221; practices and poor reporting standards in studies on machine learning-based prediction models. <italic toggle="yes">J. Clin. Epidemiol.</italic><bold>158</bold>, 99&#8211;110 (2023).<pub-id pub-id-type="pmid">37024020</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jclinepi.2023.03.024</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR84"><label>84.</label><citation-alternatives><element-citation id="ec-CR84" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pruneski</surname><given-names>JA</given-names></name><etal/></person-group><article-title>Supervised machine learning and associated algorithms: applications in orthopedic surgery</article-title><source>Knee Surg. Sports Traumatol. Arthrosc.</source><year>2023</year><volume>31</volume><fpage>1196</fpage><lpage>1202</lpage><pub-id pub-id-type="doi">10.1007/s00167-022-07181-2</pub-id><pub-id pub-id-type="pmid">36222893</pub-id></element-citation><mixed-citation id="mc-CR84" publication-type="journal">Pruneski, J. A. et al. Supervised machine learning and associated algorithms: applications in orthopedic surgery. <italic toggle="yes">Knee Surg. Sports Traumatol. Arthrosc.</italic><bold>31</bold>, 1196&#8211;1202 (2023).<pub-id pub-id-type="pmid">36222893</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00167-022-07181-2</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR85"><label>85.</label><citation-alternatives><element-citation id="ec-CR85" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fernandez-Felix</surname><given-names>BM</given-names></name><name name-style="western"><surname>L&#243;pez-Alcalde</surname><given-names>J</given-names></name><name name-style="western"><surname>Roqu&#233;</surname><given-names>M</given-names></name><name name-style="western"><surname>Muriel</surname><given-names>A</given-names></name><name name-style="western"><surname>Zamora</surname><given-names>J</given-names></name></person-group><article-title>CHARMS and PROBAST at your fingertips: a template for data extraction and risk of bias assessment in systematic reviews of predictive models</article-title><source>BMC Med. Res. Methodol.</source><year>2023</year><volume>23</volume><fpage>44</fpage><pub-id pub-id-type="doi">10.1186/s12874-023-01849-0</pub-id><pub-id pub-id-type="pmid">36800933</pub-id><pub-id pub-id-type="pmcid">PMC9936746</pub-id></element-citation><mixed-citation id="mc-CR85" publication-type="journal">Fernandez-Felix, B. M., L&#243;pez-Alcalde, J., Roqu&#233;, M., Muriel, A. &amp; Zamora, J. CHARMS and PROBAST at your fingertips: a template for data extraction and risk of bias assessment in systematic reviews of predictive models. <italic toggle="yes">BMC Med. Res. Methodol.</italic><bold>23</bold>, 44 (2023).<pub-id pub-id-type="pmid">36800933</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12874-023-01849-0</pub-id><pub-id pub-id-type="pmcid">PMC9936746</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR86"><label>86.</label><citation-alternatives><element-citation id="ec-CR86" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Japkowicz</surname><given-names>N</given-names></name><name name-style="western"><surname>Stephen</surname><given-names>S</given-names></name></person-group><article-title>The class imbalance problem: A systematic study</article-title><source>Intell. Data Anal.</source><year>2002</year><volume>6</volume><fpage>429</fpage><lpage>449</lpage><pub-id pub-id-type="doi">10.3233/IDA-2002-6504</pub-id></element-citation><mixed-citation id="mc-CR86" publication-type="journal">Japkowicz, N. &amp; Stephen, S. The class imbalance problem: A systematic study. <italic toggle="yes">Intell. Data Anal.</italic><bold>6</bold>, 429&#8211;449 (2002).</mixed-citation></citation-alternatives></ref></ref-list></back></article></pmc-articleset>